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Abstract
Machine learning is an area of computer science concerned with the study of
algorithms that reveal patterns and rules from data sets. Genomic profiles
describe alterations of a genome, like copy number variations. Cancer often
originates from a combination of genomic alterations.
In this thesis, I consider machine learning and its application to genomic
profiles. The main aspects of this work can be summarised as follows:
First, I discuss several machine learning methods, with particular regard to
genomic profiles, and then develop a special loss function for survival data.
Next, I introduce a framework to find aberration patterns associated with
a particular tumour type or disease state. This workflow starts with pre-
processing, feature selection and discretisation of genomic profiles, includes
strategies to deal with missing values and provides a multi-resolutional ana-
lysis. Then, training and analysis of a classifier is performed.
Additionally, I introduce an explanation component that emphasizes impor-
tant features of the classification process and estimates the certainty of clas-
sification results. Such an explanation method could provide the basis for the
integration of a classification algorithm, such as a support vector machine,
in a clinical decision support system.
The methods proposed in the thesis were applied to various data sets, focus-
sing on important biological questions, such as early metastasis and micro-
metastasis, and lead to the detection of new tumour markers.
The results of these investigations indicate that machine learning methods
can enhance our understanding of genomic aberrations and may help to im-
prove the delivery of therapies to cancer patients.
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Zusammenfassung
Gegenstand dieser Arbeit ist das maschinelle Lernen und seine Anwendung
auf genomische Profile.
Maschinelles Lernen ist ein Teilbereich der Informatik, der sich mit der Ana-
lyse und dem Design von Algorithmen bescha¨ftigt, die Regeln und Muster
aus Datensa¨tzen ableiten. Genomische Profile beschreiben Vera¨nderungen
der DNA, z.B. der Anzahl ihrer Kopien. Tumorerkrankungen werden oft-
mals von diesen genomischen Vera¨nderungen hervorgerufen.
Es werden verschiedene Verfahren des maschinellen Lernens auf ihre Anwend-
barkeit in Bezug auf genomische Profile untersucht. Des Weiteren wird eine
Verlustfunktion fu¨r U¨berlebenszeitdaten entworfen.
Anschließend wird ein analytischer Bezugsrahmen entwickelt, um Aberra-
tionsmuster zu finden, die mit einer speziellen Tumorerkrankung assoziiert
sind. Der Bezugsrahmen umfaßt die Vorverarbeitung, Merkmalsselektion und
Diskretisierung von genomischen Profilen sowie Strategien zum Umgang mit
fehlenden Werten und eine mehrdimensionale Analyse. Abschließend folgen
das Training und die Analyse des Klassifikators.
In dieser Arbeit wird weiterhin eine Erkla¨rungskomponente vorgestellt, die
wichtige Merkmale fu¨r die Klassifikation eines Falles identifiziert und ein
Maß fu¨r die Richtigkeit einer Klassifikation liefert. Solch eine Erkla¨rung-
skomponente kann die Basis fu¨r die Integration eines Klassifikators , z.B.
einer Support-Vektor-Maschine, in ein entscheidungsunterstu¨tzendes System
sein.
Die im Rahmen dieser Arbeit entwickelten Methoden wurden erfolgreich zur
Beantwortung von biologischen Fragestellungen wie der fru¨hen Metastasie-
rung oder der Mikrometastasierung angewandt und fu¨hrten zur Entdeckung
bisher unbekannter Tumormarker.
Zusammenfassend zeigen die Ergebnisse der vorliegenden Arbeit, dass Ver-
fahren des maschinellen Lernens zum Erkenntnisgewinn in Bezug auf geno-
mische Vera¨nderungen beitragen und Mo¨glichkeiten zu einer weiteren Ver-
besserung der Therapie fu¨r Tumorpatienten aufzeigen.
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Chapter 1
Introduction
1.1 Overview
Cancer can be caused by, and often correlates with, a combination of ge-
nomic alterations. A better understanding of these genomic alterations will
lead to improved diagnostic schemes and finally to additional therapeutic
interference points [WLS+01, SKS+02, Saw03].
In the last two decades, a manifold of experimental techniques has emer-
ged to investigate genomic alterations in cancer patients at different levels
of resolution. Currently, techniques such as comparative genomic hybridisa-
tion (CGH), loss of heterozygosity (LOH) and especially matrix-CGH, are
revolutionising cancer research.
CGH, matrix-CGH and LOH can provide a comprehensive, genome-wide
analysis of genomic alterations and describe the genomic profile of each tu-
mour. The dimensionality and complexity of genomic profiles demand the
application of computer-based methods. Important methods for analysing
and modelling the underlying structure of genomic aberrations originated
from the field of machine learning.
Questions that can be answered by machine learning are:
• What are the typical aberrations of a specific tumour type?
• Are different tumour types distinguishable?
• Which aberrations distinguish one tumour type from another?
1
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• Are genomic aberrations associated with certain clinical variables, such
as tumour grading, lymph node status, age, gender and tumour size?
• Can the (relapse, metastasis or survival) risk of an individual patient
be estimated based upon genomic profiles, and how?
• Can genomic profiles be used to tailor the appropriate therapy for a
specific patient in cancer treatment, and how?
1.2 How machines learn
Machine learning is an interdisciplinary field including, but not limited to:
artificial intelligence (AI), statistics and information theory.
The term ”machine”, as utilised in AI, refers to a program running on a
multi-purpose computer, rather than to a mechanical device.
Historically, one main motivation of AI has been to develop a tool that can
solve all problems posed - in essence, a general problem solver [NS61]. Howe-
ver, this ambitious goal has not been fulfilled and the direction of research has
increasingly shifted towards using AI for the solution of well-defined problems
in separable domains [McC04, RN95].
One well-defined problem is the automatic assignment of pattern (e.g., pic-
tures) to classes (e.g. category apples versus category peaches). This has
been a goal of AI from the beginning. For example, in 1955, Selfridge and
Dinneen [Sel55, Din55] presented a model of a system which should learn
to recognise visual patterns like the letters ”A” and ”O”. Selfridge propo-
sed to ”feed the machine A’s and O’s, telling the machine each time which
letter it is.” Furthermore, he suggested searching assignment rules from ran-
domly chosen combinations of basis operations (basis functions) such that
they discriminate A’s and O’s.
Machine learning reveals mathematical assignment rules from a set of classi-
fied example objects (e.g., pictures of apples and pictures of peaches). Finally,
a new object can be automatically assigned to one class or the other (e.g.,
apples or peaches).
Learning based on examples relies on the induction principle of philosophy.
Induction means that general rules (laws) about future observations are in-
ferred from a limited number of observations in the past. But ”what is the
justification for the belief that the future will resemble the past?” ([Pop72]).
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If we observed only green apples in the past, we would conclude that all
apples are green. In fact, a machine learning algorithm would generalise
from a training set of green apples and red peaches that all green objects are
apples and all red objects are peaches. However, if we would apply the lear-
ned classifier to red apples in the future, they may be detected as peaches.
The underlying problem of stationarity will be covered in section 2.2.
Machine learning involves searching through a space of available assignment
rules (hypotheses). The goal is to find the simplest hypothesis that fits the
available data and prior knowledge. Problems directly derived from this
definition are:
• What is the space of available hypotheses (function space)?
• What is a useful search strategy?
• How can the quality of fit between data and hypotheses be estimated?
• How can the simplicity/complexity of a hypothesis be assessed?
These problems will be discussed further in chapter 2.
In addition to traditional issues of machine learning, I consider here also the
task of explaining the results derived from machine learning to a user who
might not be familiar with this field. Imagine a classifier calculated that an
object is an apple. So we may ask the questions:
• Why did the classifier decide that this object is an apple?
What are the most important features for classifying this object as an
apple?
• What is the probability that this object is an apple?
• Is the classifier competent to make this decision? Has it ever been
trained with apples? Is the induction from example objects possible?
The answers to these questions can lead to an integration of models discovered
by machine learning into decision support systems and will be discussed in
section 4.4.1.
All machine learning algorithms applied in this thesis can be efficiently simu-
lated by a Turing machine and multi-purpose digital computers. Interestin-
gly, we can also consider learning algorithms derived from a class of recurrent
artificial networks (ARRN) with real weights (and infinite precision) that can-
not be computed by Turing machines, but may mimic classification problems
of natural phenomena [Sie99]. However, this is not only beyond the ”Turing
limit”, but also beyond the scope of this thesis.
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1.3 Outline
The remainder of this thesis is organised into five major parts.
Chapter 2 reviews some basics of machine learning and statistical learning
theory.
Chapter 3 provides some fundamental insights into the biology of cancer,
genomic aberrations, genomic profiles and the underlying experiments. The
focus of the genomic profiles under consideration clearly lies in the field of
cancer research.
Chapter 4 derives a workflow for machine learning of genomic profiles. This
workflow includes data preprocessing, feature selection, classifier design and
evaluation. An explanation component, which emphasises important fea-
tures of the classification process and estimates the certainty of classification
results, is introduced.
Chapter 5 presents various results where this workflow has been successfully
applied.
Chapter 6 discusses and concludes the results. Finally, future directions of
research are outlined.
This thesis includes material published in [FSW+02, WSG+03, VKM+04,
SMF+03, WBZ+05, STJE05, SMH+05, SRS+06, HGS+08].
Chapter 2
Machine learning
2.1 Introduction to machine learning
This chapter gives an overview of known machine learning methods as far as
they are of importance in the domain of genomic profiles. My own contribu-
tion consists of a formulation of an SVM for survival data (section 2.4.3).
Machine learning is an interdisciplinary field based on artificial intelligence,
(Bayesian) statistics, control theory, information theory, complexity theory,
psychology and philosophy [Mit97].
The focus of machine learning under consideration is classification. The
task of classification can be defined as finding a rule which assigns classes
to objects due to their observed properties. These rules are mathematical
functions which are learnt from objects with observed properties and known
class assignments. Finally, the decision function should assign the correct
class to unseen objects.
The objects of classification problems in the domain of genomic profiles are
often cases (e.g., patients, distinct tumour samples from patients, animals,
cell culture samples). Let us define a genomic profile for the moment as a
real-valued vector, each element representing a so-called copy number ratio
(see chapter 3 for a detailed discussion). Properties of objects (e.g., colour)
are called features and their observed values (e.g., red) feature values. The
decision function is sometimes also called a learning machine or a learner.
The formal setting of this learning problem can be formalised as follows
[Vap95, Mik02, Ra¨t01, Sch97, MMR+01].
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2.2 Formal setting
Given is a training set S = {(xi, yi) ∈ X × Y|i = 1, ...,M} of M cases.
Each xi is an input or feature vector. X is the input space, often R
N . Each
dimension of X represents a feature Ai, i = 1, ..., N . The nature of the target
variable Y depends on the problem to be solved. A regression problem is
characterised by Y = R whereas a classification problem with K classes is
defined by Y = {1, ..., K}. For the special case of K = 2 the class labels are
defined as Y = {−1,+1}.
In the domain of this thesis, the set X describes genomic profiles whereas Y
refers to different tumour types. The goal is often to find a learner modelling
the relationship between features (genomic profiles) and (tumour) classes.
This can also be considered as estimating a function f(x) : X → Y. For a
two class problem, a classified case is assigned to class +1 if f(x) ≥ 0 and to
the class −1 if f(x) < 0. An example of such a decision function would be
a hyperplane f(x) = sign(〈ω,x〉 + b), with a hyperplane direction vector ω
and a constant b.
We assume that there exists an unknown probability distribution over X×Y
with density p(x, y) that describes our data generating process. Our sample
set S is now drawn identically and independently distributed (i.i.d) from this
distribution. An example distribution would consist of the genomic profiles
of all breast cancer patients in Germany from 1990 to 2000. We require that
the distribution is stationary. This implies that the typical genomic profiles
of patients at the time of surgery should not change over time.
This assumption seems to be very strong for our application. Often we disco-
ver experimentally caused changes (e.g., new therapeutic guidelines, increa-
sing expert knowledge of an experimenter). Finally, I propose a competence
estimation (section 4.4.2) to deal with this problem.
Once we obtain a decision function f(x), we would like to evaluate it. How
can the decision function be evaluated? How can the quality of fit between
the training data S and the decision function be estimated?
We will also see later that the construction of an optimal decision function
depends on the chosen criteria for the evaluation of a decision function.
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2.3 Model assessment
2.3.1 Expected risk and loss functions
Ideally, the decision function should always assign the correct class to a case.
However, if two cases share the same feature values but belong to different
classes, both classes are not always separable.
Therefore, our goal is to find the function f∗ from the function space F that
minimises the number of wrong assignments, or formally the expected risk
(generalisation error) R(f):
f∗ = argmin
f∈F
R(f). (2.3.1)
This error is defined on the entire distribution (e.g. of all breast cancer cases)
and not only on the cases observed:
R(f) =
∫
L(y, f(x))dp(x, y). (2.3.2)
L is a loss function, measuring the difference between the predicted (f(x))
and the true (y) outcome. Examples of loss functions used in this thesis are
given in table 2.1.
2.3.2 Empirical risk
However, we do not know the underlying probability density p(x, y). But we
can try to estimate a so-called empirical risk, based on the available cases S:
Remp(f,S) =
1
M
M∑
n=1
L(yn, f(xn)). (2.3.3)
A minimisation of the empirical risk can lead to overfitting (Fig. 2.1). In
the case of overfitting, a complex decision function is fitted to the set of
available cases such that the decision function reflects the training data and
not the entire distribution. Overfitting can often be avoided by choosing
simpler decision functions (e.g., linear or quadratic). Occam’s razor, a general
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Name Description Definition
Squared
(L2) loss
Common loss func-
tion for regression
problems
L2(y, f(x)) = (f(x)− y)2
0/1-loss
Empirical mo-
del assessment
of classification
problems
L0/1(y, f(x)) =
{
0 for y = f(x)
1 for y 6= f(x)
L1 loss
Derivation of boos-
ting (see section
2.4.7)
L1(y, f(x)) = |f(x)− y|
ǫ-
insensitive
L1 loss
Derivation of sup-
port vector regres-
sion
Lǫ(y, f(x)) = max (0, |y − f(x)| − ǫ)
Table 2.1: Loss functions
principle of inductive learning, states that the most likely hypothesis is the
simplest one that is consistent with all observations.
Subsequently, the estimation of the expected risk can be improved by consi-
dering the complexity of the decision function.
Complex classifiers can be penalised by regularisation and the regularised
empirical risk is given by:
Rreg = Remp(f,S) + CΦ(f). (2.3.4)
C is a penalty factor, balancing empirical risk and classifier complexity. The
appropriate choice of C is critical. Φ : F → R+ denotes a regularisation
operator, measuring the complexity or smoothness of the decision function
f(x).
Finally, it seems worthwhile to include the complexity of the decision function
in the model assessment. This can be done by calculating the minimum
description length.
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Figure 2.1: Two hypotheses were fitted to the training data. Hypothesis A uses a
simpler decision function and is therefore much more likely to reflect the underlying
distribution. Hypothesis B is likely to be overfitted.
2.3.3 Minimum description length
The idea of the minimal description length is to write the shortest binary
program to reproduce a given data set [Ris78]. Surely, using regularities in
the data set will help to find the shortest description and this underlying idea
is used in compression algorithms. It’s worthwhile to note that a Bayesian
view of the minimal description length and a close link to coding theory also
exists (see [Mac03]).
The minimum description length is defined as the shortest description (in
bits) of the decision function: L(f(x)) and the residuals of the training data
given the decision function: L(S|f(x)). The model with the shortest descrip-
tion is defined by:
f∗ = argmin
f∈F
(L(f(x)) + L(S|f(x))). (2.3.5)
A Bayesian (statistical) notation can be easily derived by maximising the
probability P (f |S) and using Bayes’ law P (f |S) = P (S|f)P (f)
P (S)
. Note that P (S)
is known for a given data set S.
f∗ = argmin
f ∈F
(− log2(P (f(x)))− log2(P (S|f(x)))) (2.3.6)
The minimum description length can be used to compare different decision
functions. It balances the complexity of the decision function, derived from
the training data, and the empirical risk. A complex decision function has a
larger code length than a simpler one. If the decision function is too simple,
the empirical risk is higher and a larger code length is needed to encode the
residuals of the training data.
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2.3.4 Vapnik-Chernovenkis dimension
Another method to measure the complexity/capacity of decision functions is
the VC-dimension [Vap95].
The VC-dimension θ of a class of functions F corresponds to the maximum
number of cases which can be shattered (learned with training error Remp=0)
by elements of this class for all possible labellings (class assignments) of these
cases (Fig. 2.2).
A B C D
E F

G H
Feature 1
Fe
a
tu
re
 2
x1
x1
x2
x2
x3
x3
x4
Figure 2.2: A) to F) A set of hyperplanes with two dimensions can shatter three
cases x1 to x3 and has therefore a VC-dimension of three. Note that x3 belongs to
class 2 (yi = −1) in A), to class 1 (yi = +1) in B) and to class 1 (yi = +1) in C).
Panel G) illustrates a class assignment for four points that cannot be separated
by a linear hyperplane. However, H) shows that other nonlinear classifiers with a
VC-dimension of at least four can still shatter (separate) four cases.
With a probability of at least 1 − δ, f ∈ F, δ > 0 and Remp be defined by
L0/1, it holds that [Vap95]:
R(f) ≤ Remp(f,S) +
√
8
M
[
θ
(
log2
2M
θ
+ 1
)
+ log2
(
4
δ
)]
. (2.3.7)
Therefore, a small VC-dimension θ prevents overfitting. The VC-dimension
can also be used to derive support vector machines (see section 2.4).
Examples of VC-dimensions are:
• Class of hyperplanes with N dimensions: VC-dimension N+1.
• Support vector machines with radial basis kernels: infinite VC-dimension.
Unfortunately in practice, the bounded risk in (2.3.7) ”is often neither easily
computable nor very helpful” [MMR+01].
Finally, the simplest idea to evaluate a classifier is to apply it to unseen data.
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2.3.5 Independent test set
The test error estimates the expected risk and is calculated from the number
of classification errors on an independent test set.
The test set is created by randomly dividing the data set of all observed cases
in three disjoint sets:
• a training set,
• a validation set and
• a test set.
The training set is used for classifier training, the validation set for estimating
the expected risk of different classifiers and the test set for estimating the
expected risk of the finally chosen classifier. See also section 4.3.
2.3.6 Cross-validation
If only a few cases are available then it is impossible to set aside an inde-
pendent test set for model assessment. Instead, we can subdivide the avai-
lable data into k approxiametely equally sized parts and use (k − 1) parts
for training and one part for testing. Iteratively, each part is used once
for testing and (k − 1) times for training. This procedure is called k-fold
cross-validation.
The error estimation is then averaged over all parts, with f−k(i)(xi) being
the classifier trained on all but the ith part and nk being the number of cases
in part k:
Rcross =
1
k
k∑
i=1
1
nk
nk∑
j=1
L(yij, f−k(i)(xij)). (2.3.8)
Kohavi proposed a stratified cross-validation, where each part includes the
same proportion of cases from each class [Koh95a].
IfK =M then cross-validation is called leave-one-out-cross-validation (LOO-
CV). LOO-CV has a lower bias but a higher variance compared with a cross-
validation with K=10 (ten-fold cross-validation) [HTF01].
An alternative algorithm, especially for small data sets, is called bootstrap.
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2.3.7 Bootstrap
First, a random sample is drawn with replacement from the available data.
The cases that are not part of this sample are called out-of-the-bag data. The
sample contains approximately 63.2% of all cases. The classifier is trained
with the random sample and tested on the out-of-the-bag data. This process
is repeated and an average test error Rtest is estimated.
Finally, the bootstrap error is calculated as a weighted average of the test
error Rtest and the training error on the whole dataset Remp:
Rboot = 0.632Rtest + (1− 0.632)Remp. (2.3.9)
The factor 0.632 is only based on plausibility and should be adapted in case
of overfitting by considering a ”no information error rate” [HTF01].
An empirical comparison of model assessment techniques and remarks on
their reproducibility can be found in section 4.3.3.
2.4 Support vector machines
2.4.1 Key ideas
Following the definition of the VC-dimension (2.3.7), two different kinds of
constructive learning algorithms can be considered [Vap95]:
1. Construct a machine with a given VC-dimension and minimise the em-
pirical risk. This principle is implemented in artificial neural networks.
2. Construct a machine with a given empirical risk (e.g., Remp = 0) and
minimise the VC-dimension. This principle is used in support vector
machines.
The support vector machine (SVM) classification algorithm combines two
key ideas [Vap95].
The first idea of SVMs is to find an optimal separating hyperplane f(x) =
sign(〈ω,x〉 + b) with bias b that maximises the margin ρ between the two
classes (e.g. tumour types). The margin ρ is defined as the minimum Eucli-
dean distance of a case xi from the decision hyperplane (see Fig. 2.3) and can
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Figure 2.3: Linear decision function separating class 1 from class 2. Each circle
or square refers to one case xi. Full circles and squares denote the support vectors
s1 to s5. The margin is the distance from the hyperplane to a support vector.
be maximised by minimising the length of the hyperplane direction vector
ω. Fig. 2.4 motivates the optimisation problem.
More formally, the VC-dimension θ of a separating hyperplane is bounded
by the norm of the hyperplane direction vector ||w||2:
θ ≤ min{r2||w||22,M}+ 1 (2.4.1)
where r is the radius of the smallest sphere around the training data. Note
that r is fixed for a given data set S. Furthermore, it is required that Remp =
0 or yn(〈ω,xi〉 + b) ≥ 1 for n = 1, ..,M . SVMs can only deal with two-
class classification problems (yi ∈ {−1, 1}). Subsequently, it follows this
optimisation problem:
minimise
ω,b
1
2
‖ω‖22 (2.4.2)
subject to yi(〈ω,xi〉+ b) ≥ 1 for i = 1, ..,M.
Maximising the margin (2.4.3) is equivalent to minimising the length of the
hyperplane direction vector (see section 2.4.2 for details). Therefore, the
hyperplane found by the above problem is equivalent to the hyperplane found
by maximising the margin:
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maximise
ω,b,ρ
ρ (2.4.3)
subject to
{
yi(〈ω,xi〉+ b) ≥ ρ for i = 1, ..,M
‖ω‖22 = 1
By requiring the scaling of ‖ω‖22 = 1, a canonical form of the hyperplane
(ω, b) is defined.
If the cases are not separable (due to noise), a soft margin and so-called
slack variables ξi, ξ
∗
i are introduced. The slack variables ξi and ξ
∗
i model a
possible margin violation of case xi. The use of slack variables is penalised
class 1 class 2
separating hyperplane
A
DC
B
Feature 1
Fe
a
tu
re
 2
Figure 2.4: Different hyperplanes separate the data set (A and B). Maximising
the margin around each data point determines the position of the hyperplane (C
and D). Finally, three support vectors (bold) emerge.
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by an additional regularisation parameter C. This parameter C controls the
influence of outliers (cases on the wrong side of the decision hyperplane).
The new optimisation problem is given by:
minimise
ω,b,ξ
1
2
‖ω‖22 + C
M∑
i=1
ξi, (2.4.4)
subject to
{
yi(〈ω,xi〉+ b) ≥ 1− ξi for i = 1, ..,M
ξi ≥ 0 for i = 1, ..,M.
The second key concept of SVMs is a nonlinear mapping of cases from the
input space X to a higher-dimensional space (called feature space) F. It is
not required to do the mapping explicitly in the higher-dimensional feature
space because the (mapped) feature values only occur within scalar products
in the algorithm. The kernel K(x1,x2) = 〈Ψ(x1),Ψ(x2)〉 calculates these
scalar products in the feature space. This is called the ”kernel-trick”. See
also Fig. 2.5.
A B
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f. 3
*
Figure 2.5: A projection from the two-dimensional input space (A) to the three-
dimensional feature space (B) enables a separation by a linear hyperplane. Feature
1∗, feature 2∗ and feature 3∗ (abbr. f.3∗) are (non-)linear combinations of feature
1 and feature 2.
The resulting classifier
f(x) = sign(
M∑
i=1
αiyiK(si,x) + b) (2.4.5)
is linear in feature space, but not necessarily in input space. Kernelised ver-
sions of maximum margin discriminants are called support vector machines.
The support vectors si are those training examples lying closest to the hyper-
plane and yi are their class labels. The corresponding coefficients αi and the
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bias constant b reflect the solution of the quadratic programming problem
and define the position of the separating hyperplane.
Different kernels can be applied to support vector machines. The linear kernel
K(si,x) = s
t
i
x =
N∑
j=1
(sijxj) (2.4.6)
and the polynomial kernel
K(si,x) = (c+ γs
t
i
x)d = (c+ γ
N∑
j=1
sijxj)
d (2.4.7)
are examples where N is the dimensionality of the input space and c, d, γ are
constants.
See section 2.4.4 for a detailed discussion regarding kernel functions.
Support vector machines have shown very good generalisation performance
([MLH03]). SVMs perform well on small training sets and always find the
global optimum of the hyperplane in the training process. Thus, they are a
good alternative to artificial neural networks.
2.4.2 Derivation of the support vector machine algo-
rithm
In the following section, two ways to derive support vector machines are
outlined. Vapnik motivated support vector machines by the large margin
[Vap95]. However, SVMs can also be derived using regularisation theory
instead of the large margin [Gir98, EPP00, SSM98].
Motivation of SVMs by a large margin
A support vector machine classifier motivated by the maximum margin would
be the solution of the following problem:
maximise
ω,b,ρ
ρ (2.4.8)
subject to
{
yi(〈ω,xi〉+ b) ≥ ρ for i = 1, ..,M
‖ω‖22 = 1.
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By requiring the scaling of ‖ω‖22 = 1, a canonical form of the hyperplane
(ω, b) is defined.
However, this is a difficult optimisation problem (due to nonlinear constraints).
An equivalent optimisation problem is given by [Vap95]
minimise
ω,b
1
2
‖ω‖22 (2.4.9)
subject to yi(〈ω,xi〉+ b) ≥ 1 for i = 1, ..,M.
The solution ω∗ of problem (2.4.8) and the solution ω∗∗ of problem (2.4.9)
relate to each other as follows:
ω∗ =
ω∗∗
‖ω∗∗‖ . (2.4.10)
To construct a SVM that is nonlinear in the input space, the linear hyperplane
is relocated in the feature space:
minimise
ω,b
1
2
‖ω‖22 (2.4.11)
subject to yi(〈ω,Ψ(xi)〉+ b) ≥ 1 for i = 1, ..,M.
Note, that the parameter b and ω are situated in the feature space. There-
fore, the easier dual Wolfe problem LD (2.4.13) is solved. This is obtained
by analysing the primal problem according to Lagrange and introducing La-
grangian multipliers αi:
minimise
ω,b
LP =
1
2
‖ω‖22 −
M∑
i=1
αi(yi(〈ω,Ψ(xi)〉+ b)− 1) (2.4.12)
subject to αi ≥ 0 for i = 1, ..,M.
At the optimal (saddle) point, the first derivatives of LP with respect to b
and ω are zero which leads to
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M∑
i=0
αiyi = 0 and ω =
M∑
i=0
αiyiΨ(xi)
and can substituted back into LP (2.4.12).
Finally, using K(xi,xj) = 〈Ψ(xi),Ψ(xj)〉, the dual problem LD is given by
maximise
α
LD =
M∑
i=1
αi − 1
2
M∑
i=1,j=1
αiαjyiyjK(xi,xj) (2.4.13)
subject to
{
αi ≥ 0 for i = 1, ..,M∑M
i=0 αiyi = 0
The solution of this problem can be found by using a quadratic program
solver like quadprog in Matlab. See also section 2.4.6.
In the case of noise, the original SVM problem is given by
minimise
ω,b
1
2
‖ω‖22 + C
M∑
i=1
ξi, (2.4.14)
subject to
{
yi(〈ω,Ψ(xi)〉+ b) ≥ 1− ξi for i = 1, ..,M.
ξi ≥ 0 for i = 1, ..,M.
with the Wolfe dual
maximise
M∑
i=1
αi − 1
2
M∑
i=1,j=1
αiαjyiyjK(xi,xj) (2.4.15)
subject to
{
0 ≤ αi ≤ C for i = 1, ..,M∑M
i=0 αiyi = 0
This problem is actually solved by an SVM. Note, that the only difference
between the hard and soft margin optimisation problem of the SVM is an
additional upper bound of the Lagrange multipliers αi. Furthermore, all cases
with a Lagrange multiplier αi 6= 0 are called support vectors and all cases
with αi = C are outliers (lying on the wrong side of the decision hyperplane).
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Motivation of SVMs using regularisation theory
In terms of regularisation theory, the minimisation problem is given by:
minimise
f∈F
C
M∑
i=1
L(yi, f(xi)) + 1
2
Φ(f(x)). (2.4.16)
The function space F is here a Reproducing Kernel Hilbert Space (RKHS)
and the decision function f(x) has an unique expansion
f(x) =
∞∑
j=1
cjφj(x) (2.4.17)
where φj are linearly independent functions and cj are coefficients. It is
assumed that one of the basis functions φj is constant, otherwise an additional
parameter b has to be added.
The scalar product in the RKHS is given by
〈f1, f2〉H =
〈
∞∑
j=1
c1jφj,
∞∑
j=1
c2jφj
〉
H
=
∞∑
j=1
c1jc2j
λj
(2.4.18)
and the norm has the form
‖f‖2
H
= 〈f, f〉
H
=
∞∑
j=1
c2j
λj
(2.4.19)
where {λn}∞n=1 is a decreasing positive sequence.
The regularisation operator Φ(f(x)) is the norm:
Φ(f(x)) = ‖f‖2
H
=
∞∑
j=1
c2j
λj
. (2.4.20)
By choosing Φ(f(x)) as ‖f‖2
H
, the solution of the optimisation problem
(2.4.16) has always the form [Gir98]
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f(x) =
M∑
i=1
aiK(x, si) + b. (2.4.21)
The kernel function
K(x1,x2) =
∞∑
j=1
λjφj(x1)φ
∗
j(x2) (2.4.22)
has the reproducing property
f(x1) = 〈f(x2), K(x2,x1)〉H . (2.4.23)
and can be used to construct an RKHS.
The space {(φj(x))∞j=1,x ∈ X} is called the feature space F induced by the
kernel K.
An example for a kernel function would be a radial basis kernel where the φj
are Fourier components [EPP00]:
K(x1,x2) =
∞∑
j=1
λje
i2πjx1e−i2πjx2). (2.4.24)
The use of the ǫ-insensitive loss function in the optimisation problem leads to
an approximation scheme of an SVM. Note, that we consider here a regression
problem. However, any SVM classification problem can be solved as an SVM
regression problem [EPP00].
The optimisation problem
minimise
f∈F
C
M∑
i=1
Lǫ(yi, f(xi)) + 1
2
‖f‖2
H
(2.4.25)
has to be replaced by an equivalent one to deal with the Lǫ loss function
[Gir98]
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minimise
f∈F,ξi,ξ∗i
C
M∑
i=1
(ξi + ξ
∗
i ) +
1
2
∞∑
j=1
c2j
λj
(2.4.26)
subject to

f(xi)− yi ≤ ǫ+ ξi for i = 1, ..,M
yi − f(xi) ≤ ǫ+ ξ∗i for i = 1, ..,M
ξi ≥ 0 for i = 1, ..,M
ξ∗i ≥ 0 for i = 1, ..,M.
The Lagrangian corresponding to this problem with Lagrangian multipliers
αi, α
∗
i and βi is:
minimise
f∈F,ξi,ξ∗i ,α,α
∗,ξ,ξ∗
C
M∑
i=1
(ξi + ξ
∗
i ) +
1
2
∞∑
j=1
c2j
λj
+
M∑
i=1
α∗i (yi − f(xi)− ǫ− ξ∗i )
(2.4.27)
+
M∑
i=1
αi(f(xi)− yi − ǫ− ξi)−
M∑
i=1
(βiξi + β
∗
i ξ
∗
i )
subject to αi, α
∗
i , βi, β
∗
i ≥ 0 for i = 1, ..,M.
If the derivatives are zero, it follows
cj = λj
M∑
i=1
(α∗i − αi)φj(xi) (2.4.28)
and
M∑
i=1
(α∗i − αi) = 0. (2.4.29)
Substituting back into the definition of the decision function 2.4.17, one ob-
tains:
f(x) =
M∑
i=1
(α∗i − αi)K(x, si) + b. (2.4.30)
The αi and α
∗
i have to be determined from the following quadratic program-
ming problem [Gir98]:
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minimise
αi,α∗i
ǫ
M∑
i=1
(αi + α
∗
i )−
M∑
i=1
yi(α
∗
i − αi) (2.4.31)
+
1
2
M∑
i,j=1
(α∗j − αj)(α∗i − αi)K(xi, xj)
subject to
{
0 ≤ αi, α∗i ≤ C for i = 1, ..,M∑M
i=1(α
∗
i − αi) = 0 for i = 1, ..,M
Summarising, SVMs for regression and classification can be derived within
the regularisation framework by using a special loss function.
2.4.3 Support vector machine survival regression ba-
sed on censored observations
Basic idea
Let us consider a special case of regression problems. The aim here is to
estimate the time until an event occurs (e.g., healing, relapse, heart attack
or death of a patient) based on a feature vector xi. Survival times are often
only partially observed. This is the case for patients still alive at the end
of a study or lost to follow-up. Incomplete observations are called censored
observations.
This information is stored in a vector cens where each element is 0 for a
censored and 1 for a not censored observation. Imagine a breast case study
over 15 years (see Fig. 2.6). If a person leaves the study (for whatever reason)
or is still alive at the end of the study, we don’t know the true survival time
of this person. However, we know that the true survival time is not lower
than the time observed.
My idea to estimate survival times with a support vector machine is based
on a special loss function Lsurv (Fig. 2.7). This loss function is defined as
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Figure 2.6: Censored observations in a study. A) Death of a patient was observed
in year 8 (not censored). B) Patient left study in year 8 (censored). C) Patient
was still alive at the end of the study (censored).
Lsurv(yi, f(xi)) =

0 for |yi − f(xi)| ≤ ǫ
|yi − f(xi)| − ǫ for yi − f(xi) > ǫ and censi = 1
|yi − f(xi)| − ǫ for f(xi)− yi > ǫ and censi = 1
|yi − f(xi)| − ǫ for yi − f(xi) > ǫ and censi = 0
0 for f(xi)− yi > ǫ and censi = 0.
(2.4.32)
Important features of this loss function are:
• For non-censored observations, this loss function is equivalent to the
ǫ-insensitive loss Lǫ.
• Margin violations of censored cases are not penalised if the estimated
survival time is greater than the observed survival time.
Note that here we are only dealing with right censored data, where we know
the starting but not always the end point. However, in principle, all consi-
derations also hold for left censored data.
The proposed regression method is only valid if the reasons for observing a
censored observation are unrelated to the features x of a case.
Derivation of the optimisation problem
The optimisation problem given the Lsurv loss function is:
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Figure 2.7: Loss function Lsurv for ǫ = 0.3. A) not censored case B) censored
case.
minimise
f∈F
C
M∑
i=1
Lsurv(yi, f(xi)) + 1
2
‖ω‖22 (2.4.33)
In analogy to the support vector regression, it has to be replaced by an
equivalent one to deal with the Lsurv loss function (compare (2.4.25)):
minimise
f∈F,ξi,ξ∗i
C
M∑
i=1
(ξi(1− censi) + ξ∗i ) +
1
2
‖ω‖2 (2.4.34)
subject to

f(xi)− yi ≤ ǫ+ ξi for i = 1, ..,M
yi − f(xi) ≤ ǫ+ ξ∗i for i = 1, ..,M
ξi ≥ 0 for i = 1, ..,M
ξ∗i ≥ 0 for i = 1, ..,M
The overall penalty factor C is now replaced by two penalty vectors C and
C∗ to penalise case-specific margin violations.
C∗i is set to C for all cases (as long as we consider right censored data). Ci
is zero for censored cases and C for not censored cases.
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minimise
f∈F,ξi,ξ∗i
M∑
i=1
(ξiCi + ξ
∗
iC
∗
i ) +
1
2
‖ω‖2 (2.4.35)
subject to

〈ω,Ψ(xi)〉+ b− yi ≤ ǫ+ ξi for i = 1, ..,M
yi − 〈ω,Ψ(xi)〉 − b ≤ ǫ+ ξ∗i for i = 1, ..,M
ξi ≥ 0 for i = 1, ..,M
ξ∗i ≥ 0 for i = 1, ..,M
Note, that the parameter b and ω are situated in the feature space. There-
fore, the easier dual Wolfe problem is solved. This is obtained by analysing
the primal problem according to Lagrange and introducing Lagrangian mul-
tipliers αi, α
∗
i ηi, η
∗
i for each inequality constraint:
minimise
ω,b
LP =
1
2
‖ω‖22 +
M∑
i=1
Ciξi + C
∗
i ξ
∗
i −
M∑
i=1
(ηiξi + η
∗
i ξ
∗
i ) (2.4.36)
−
M∑
i=1
αi(ǫ+ ξi + yi − 〈ω,Ψ(xi)〉 − b)
−
M∑
i=1
α∗i (ǫ+ ξ
∗
i − yi + 〈ω,Ψ(xi)〉+ b)
subject to αi, α
∗
i , ηi, η
∗
i ≥ 0 for i = 1, ..,M.
At the optimal (saddle) point, the first derivatives of LP with respect to b
and ω are zero which leads to
∂LP
∂ω
= ω +
M∑
i=1
(Ψ(xi)αi)−
M∑
i=1
(Ψ(xi)α
∗
i ) = 0 (2.4.37)
∂Lp
∂b
=
M∑
i=1
(αi)−
M∑
i=1
(α∗i ) = 0 (2.4.38)
∂Lp
∂ξi
= Ci − αi − ηi = 0 (2.4.39)
∂LP
∂ξ∗i = C
∗
i − α∗i − η∗i = 0 (2.4.40)
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and can be substituted back into LP (2.4.36).
Finally, using K(xi,xj) = 〈Ψ(xi),Ψ(xj)〉, the dual problem is given by
maximise
αi,α∗i
−ǫ
M∑
i=1
(αi + α
∗
i ) +
M∑
i=1
yi(α
∗
i − αi) (2.4.41)
−1
2
M∑
i,j=1
(α∗i − αi)(α∗j − αj)K(xi, xj)
subject to

0 ≤ αi ≤ Ci for i = 1, ..,M
0 ≤ α∗i ≤ C∗i for i = 1, ..,M∑M
i=1(α
∗
i − αi) = 0 for i = 1, ..,M
which can be solved by a quadratic program solver.
Note, that the only difference from a normal SVM regression problem is that
individual constraints limit the αi for censored data points.
Discussion
An alternative regression method for censored observations is the exponential
regression model [HL99]
T = eβ0+β1x. (2.4.42)
The coefficients β0 and β1 are fitted by maximum likelihood estimation
(MLE).
Therefore, the log-likelihood function is maximised:
L(β0, β1) =
M∑
i=1
censi [yi − (β0 + β1xi)]− e[yi−(β0+β1xi)]. (2.4.43)
In order to obtain the MLE, the derivatives of L(β0, β1) are set to zero.
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∂L(β0, β1)
∂β0
=
M∑
i=1
(
censi − e[yi−(β0+β1xi)]
)
= 0 (2.4.44)
∂L(β0, β1)
∂β1
=
M∑
i=1
xi
(
censi − e[yi−(β0+β1xi)]
)
= 0 (2.4.45)
These equations have to be solved using an iterative numerical method.
The only SVM survival approach I am aware of, was presented in a talk by
Ha¨rdle and Moro [HM04]. The idea is to divide the observed survival times
into T periods. For each period, a classifier for all patients alive at period t is
trained, this distinguishes patients that will die in period t+1 from patients
that survive period t + 1. Finally, the regression problem is reduced to T
binary classification problems.
2.4.4 Kernel
Kernels intuitively measure the similarity between two cases. Kernels desi-
gned for a special application are an effective alternative to an explicit feature
extraction.
A kernel function calculates the scalar product of two cases that are mapped
from an input space X to a feature space F:
K(x1,x2) = 〈Ψ(x1),Ψ(x2)〉 (2.4.46)
The mapping function Ψ(x) is implicitly defined by the kernel function. Ho-
wever, for some finite-dimensional kernels the mapping function Ψ(x) is quite
intuitive. For the polynomial kernel and d = 2 the mapping in the two-
dimensional case results in Ψ(x1, x2) = [1,
√
2x1,
√
2x2, x
2
1, x
2
2,
√
2x1x2]
t.
A necessary and sufficient condition for a symmetric function to be a kernel
is its positive definiteness (Mercer’s condition):
M∑
i,j=1
λiλjK(xi,xj) ≥ 0 (2.4.47)
for any set of real numbers λ1, .., λM and any set of samples.
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Moreover, any K(x1,x2) can be expanded in its eigenfunctions
K(x1,x2) =
J∑
j=1
λjφj(x1)φ
∗
j(x2) (2.4.48)
with a possible mapping function [MMR+01]:
Ψ(x) = (
√
λ1φ1(x),
√
λ2φ2(x), ...,
√
λJφJ(x)). (2.4.49)
Examples of kernel functions are given in table 2.2 [Vap95, SS98, RSS05].
An example of a string kernel is given by the WD kernel of length d:
K(x1,x2) =
d∑
k=1
βk
L−k+1∑
l=1
Q(ukl(x1) == ukl(x2)), (2.4.50)
where ukl(xi) is the sequence of length k starting at position l, Q(true) = 1,
Q(false) = 0, βk =
2(d−k+1)
d(d+1)
and L the length of the string.
Note that the exponential, Gaussian, thin plate splines and both multiquadric
kernels are translation invariant and isotropic. Translation invariant kernels
depend only on the distance vector between two samples
K(x1,x2) = KS(x1 − x2), (2.4.51)
whereas isotropic kernel functions use only the norm of the distance vector:
K(x1,x2) = KI(‖x1 − x2‖22). (2.4.52)
The question now arises, which kernel function should be chosen. For trans-
lation invariant kernels, the kernel should match prior knowledge about the
frequency distribution (power spectrum, calculated as square of the Fourier
transform of f) of the decision function f (see [Smo98]). Generally and wi-
thout previous knowledge of the decision function, Gaussian RBF kernels are
a good choice.
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Name Definition
Gaussian
radial-basis-function
kernel
K(x1,x2) = e
−γ‖x1−x2‖
2
2
Exponential kernel K(x1,x2) = e
−γ‖x1−x2‖2
Thin plate splines
kernel
K(x1,x2) = ‖x1 − x2‖22 ln ‖x1 − x2‖2
Sigmoidal kernel, only
for some values of γ
defined
K(x1,x2) = tanh(γx1x2 + δ)
Polynomial kernel of
degree d
K(x1,x2) = (c+ γx1x2)
d
Multiquadric kernel K(x1,x2) =
√
‖x1 − x2‖22 + c2
Inverse multiquadric
kernel
K(x1,x2) =
1√
‖x1 − x2‖2 + c2
Table 2.2: Kernel functions
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2.4.5 Universal approximators
Support vector machine with various kernels (e.g., sigmoidal and RBF) are
universal approximators ([HG03]). This means that they can approximate
any reasonable decision function up to a desired accuracy. The same has
been shown for feedforward neural networks (e.g., [HSW89]).
A function class F possesses universal approximation capabilities if for any
compact set C ⊂ RN , any continuous function g(x) : C → RN and any ǫ > 0
some f ∈ F can be found such that
|f(x)− g(x)| ≤ ǫ for all x ∈ C. (2.4.53)
If the function class F is used for classification only it possesses universal
approximation capabilities with respect to a probability measure P if for any
measurable function g(x) : RN → {−1,+1} and any δ > 0 some f ∈ F can
be found such that
P (x|f(x) 6= g(x)) < δ. (2.4.54)
The proof for sigmoidal kernels is based on the universal approximation ca-
pability of feedforward neural networks [HSW89], whereas the proof for RBF
kernels refers to radial basis networks and their universal approximation capa-
bility [PS91]. Polynomial kernels with unlimited degree d are also universal
approximators. However, a data set of size |S| can be approximated by a
polynomial kernel of degree d = |S| − 1 [HG03].
2.4.6 Implementation and training time complexity
Two software packages implementing SVMs have been used in this thesis.
SVMlight from Thorsten Joachims, University of Dortmund, Germany [Joa99]
and libsvm from Chih-Jen Lin, National Taiwan University, Taiwan [CL01].
A quadratic programming (QP) solver for solving the SVM problem (2.4.15)
is limited to approximately thousand samples. For larger problems, a ”chun-
king”, ”decomposition”or ”sequential minimal optimisation”technique is used
[CST00].
Chunking is based on the fact that only support vectors are important for
the solution of the QP (quadratic programming) problem. Iteratively, the
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support vectors from the last step and cases violating the optimality condi-
tions (KKT conditions) are included. Decomposition resolves the large QP
problem into very small QP problems. In the case of sequential minimal
optimisation a sub problem of only two cases is analytically solved at each
iteration [Pla99a].
The empirical scaling of state-of-the-art implementations, like SVM light, in
terms of time complexity and the number of samples is between linear (O(M))
and cubic (O(M3)) and most often quadratic (O(M2)) [Joa99, Pla99a].
More recently, Hush presented an SVM training algorithm that is bounded
by a quadratic complexity class (O(M2)) [HSS05].
Tresp and Schwaighofer discusses several approaches to narrow down the
computational complexity of the SVM learning algorithm by using a subset of
the M cases in the training set as Mbase base kernels [TS01]. The complexity
of the learning algorithm is subsequently reduced to O(M ×M2base).
Collobert and Bengio suggested a weighted ensemble of SVMs, where each
SVM is trained on a subset of the available data [CBB02]. A modification
of this approach, using equal weights of all classifiers, has been successfully
applied in a cooperation of A. Vinayagam, R. Ko¨nig, J. Moormann, KH.
Glatting, R. Eils, S. Suhai and myself [VKM+04].
2.4.7 Comparison of boosting and support vector ma-
chines
General idea of boosting
The underlying idea of boosting is to improve the classification accuracy of
an ensemble of L weak classifiers f (j) by combining them such that they
complement each other. Briefly, each classifier emphasises on cases in the
learning process that were previously wrongly classified. Finally, the weighted
majority vote of the weak classifiers determines the classification result:
fensemble(x) = sign(
L∑
j=1
αjf
(j)(x)). (2.4.55)
An example of a weak classifier would be a decision tree (see section 2.5.1)
or a decision stump (tree with one decision node).
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Adaboost
An example of a boosting algorithm is adaboost [FS96]. Adaboost assigns a
weight to each sample. Weights may be resolved, in case the weak learner
does not support weighted samples, by resampling with a probability relative
to the weight. At the beginning, all weights are equal. Later the weights
are altered according to the classification accuracy of each classifier f (j)(x).
Classifiers with Remp = 0 or Remp ≥ 0.5 are discarded.
The weights of all correctly learned samples (∀xif (j)(xi) == yi) are updated
as follows in Adaboost (version Adaboost.M1) [WF00]:
weighti,j := weighti,j
Remp(f
(j))
1−Remp(f (j)) . (2.4.56)
The weights of all wrongly learned samples (∀xif (j)(xi) 6= yi) remain unchan-
ged:
weighti,j := weighti,j. (2.4.57)
Subsequently, the relative weight of correctly learned samples decreases while
the relative weight of wrongly learned samples increases. Later, all weights
are normalised and the next iteration starts. Boosting terminates if the gain
of accuracy is smaller than a threshold or a maximal number of iterations is
reached.
For testing, a weighted average over all classifiers is used (2.4.55). The αj
are calculated from the accuracy of each classifier.
Boosting versus SVM
Interestingly, the expected risk R decreases with the number of classifiers
or boosting iterations. This can be explained by considering boosting as a
large-margin-optimisation algorithm.
Let us assume that αj =
ωj
||ω||1
and that each base function f (j) can be chosen
from a set H = {f (j)|j = 1, .., J} of J base functions f (j). The decision
function becomes
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fensemble(x) = sign(
L∑
j=1
ωj
||ω||1f
(j)(x)). (2.4.58)
Boosting can now be reformulated as a quadratic programming problem
[Ra¨t01, MMR+01] that maximises the margin ρ:
maximise
ρ,ω
ρ (2.4.59)
subject to
{
yi(
∑J
j=1 ωjf
(j)(xi)) ≥ ρ for i = 1, ..,M
||ω||1 = 1.
The maximisation of the margin ρ of a linear SVM can be written as :
maximise
ρ,ω
ρ (2.4.60)
subject to
{
yi(
∑J
j=1 ωjPj(xi)) ≥ ρ for i = 1, ..,M
||ω||2 = 1.
Pj is here an operator that projects x onto the j-th dimension (Pj(x) = xj).
Boosting maps each case explicitly to a feature space spanned by the set of
base functions. However, the use of the L1 norm (‖x‖1 =
∑ |xi|) in boosting
instead of the L2 norm (‖x‖2 =
√∑
x2i ) of an SVM leads to a sparse solution
in ω.
Training of an SVM leads to a sparse expansion in ω, where only some cases
(support vectors) contribute to the decision hyperplane.
Finally, boosting uses only the most important dimensions in feature space,
whereas SVMs use only the most important cases (support vectors).
Note that boosting implements a hard margin. [Ra¨t01] introduced therefore
a regularised boosting algorithm with a soft margin.
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2.5 Other classifiers
Two other classification algorithms, logic regression and decision trees, are
considered in this thesis. Both were chosen accordingly to their explanatory
potential.
2.5.1 Decision trees
Basic idea
A decision tree consists of internal decision nodes and terminal leaves (nodes
without children). Each internal node implements a decision and each path
to a children represents one outcome of the decision. To calculate the decision
function of the whole tree, the decision tree is recursively traversed until a
leaf node is met which assigns the class label (Fig. 2.8).
Decision trees are piece-wise axis-parallel classifiers. Training includes the
recursive partitioning of the input space to find the best separation of cases
to classes. An exhaustive search for the best decision tree (smallest tree with
Remp = 0) is often impossible. Therefore, heuristics driven by information-
theoretic measures like information gain or information gain ratio are used.
The basic training algorithm of a decision tree is recursively invoked and
starts with the root node. The feature of the first decision node is selected
by considering all features and comparing their importance. This can be done
by calculating the information gain of all features, and all possible splits and
choosing the one with the highest score. A perfect feature would separate
all cases into sets such that each set only belongs to one class. Alternatively,
the best available split is the one with the lowest impurity of the classes.
For each outcome of the decision a new children node is inserted. The recur-
sion is initiated for all cases that belong to this new node and all remaining
features.
The algorithm stops if the nodes of the tree are pure, and comprise only cases
from one class, or if the number of cases for a node is below a threshold.
Let us consider an example regarding the classification of apples, and peaches
and the features size, colour, roughness of the peeling and thickness of the
peeling. The best feature is the colour with three outcomes: green, red and
yellow. The subset with the green colour consists only of apples whereas
the subsets with a red or yellow colour are mixed. Both subsets are further
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 Chromosome 
        1A?
Class 1 Class 1
Class 1 Class 2 Class 2
 Chromosome 
        XB?
-1 0 1
-1 0 1
A B
Figure 2.8: Decision tree for the separation of two tumour classes according to
chromosomal (mouse) aberrations. -1 denotes a deletion, 0 a balanced situation
and +1 an amplification. A) shows the separation of the two classes in each node
of the tree. The histogram in node 0 visualises the overall distribution of tumour
class 1 and tumour class 2. Node 1 and Node 3 are (almost) pure and belong
to class 1. Node 6 on the other hand, contains cases from tumour class 2. The
tree and the figure were generated using the algorithm C5.0 in an implementation
of Clementine. B) sketches the decision tree and the class assignments. A case
with a deletion of chromosomal band 1A and a deletion of chromosomal band XB
would be assigned to tumour class 1 whereas a case with a balanced situation of
chromosomal band 1A and an amplification of chromosomal band XB would be
assigned to tumour class 2.
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subdivided using the features size, roughness of the peeling and thickness of
the peeling.
More formally, the algorithm starts by introducing a working set T, that
becomes initially the set S of all training cases, and a set A comprising all
features. Depending on the class distribution of the cases in T, one of the
following actions is performed [WF00, RN95]:
• The number of cases in T is greater than or equal to a threshold and
all cases in T belong to one class y :
No further split is necessary. The decision tree for T is a leaf node
associated with the class y. Terminate the algorithm for this branch.
• T contains no cases or the number of cases in T is below a threshold:
Decision tree for T is a leaf (node without children) and the class as-
sociation of this leaf has to be determined from prior knowledge. Al-
ternatively, the most frequent class is chosen. Terminate the algorithm
for this branch.
• The number of cases in T is greater than or equal to a threshold, the
cases in T belong to at least two different classes and no features are
left (|A| == 0 ):
Decision tree for T is a leaf (node without children) and the class asso-
ciation of this leaf has to be determined from background knowledge.
Alternatively, the most frequent class is chosen. Terminate the algo-
rithm for this branch.
• The number of cases in T is greater than or equal to a threshold, the
cases in T belong to at least two different classes and at least one feature
is left (|A| > 0 ):
Choose the best featureA∗ from A that subdivides the set T into subsets
such that different classes are separated by the subsets with the lowest
impurity. A feature with l different outcomes separates T into l different
subsets T
(i)
1 to T
(i)
l .
A possible score for this choice is the information gain. The gain of
feature Ai is calculated as
Gain(Ai) = I(T)−
l∑
j=1
|T(i)j |
|T| I(T
(i)
j )
with the information content of set T defined by
I(T) =
K∑
k=1
−|{(xi, yi) ∈ T|yi == k}|
|T| log2
( |{(xi, yi) ∈ T|yi == k}|
|T|
)
.
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The information gain prefers features with a large number of different
outcomes. The information gain ratio GainRatio(Ai) corrects for this
by taking into account the number of splits:
GainRatio(Ai) =
Gain(Ai)
(
∑l
j=1
|Tj |
|T|
log2
(
|Tj |
|T|
)
)
.
If the feature is continuous, consider all possible split points. At most,
|T| − 1 different splits per continuous feature are possible.
Add an internal decision node with attribute A∗. Invoke the algorithm
recursively for each subset T1 to Tl and the feature set Anew := {A −
A∗}.
If the chosen feature was continuous, it should be considered again
(with a different split point). The new feature set Anew in this case is
the old feature set A.
Decision trees use sometimes additional irrelevant features to find a tree
classifying all samples. Therefore, post-pruning is applied to reduce the
complexity of the classifier. Pruning replaces a subtree with a leaf node
and prevents splitting by irrelevant features. The relevance of a split can be
estimated by statistical tests.
From a logical point of view, decision trees are fully expressive within the
class of propositional logic. That means, any Boolean expression can be
represented by a decision tree [RN95].
Decision tree implementations
Examples of decision tree algorithms are ID3 and C4.5 ([Qui93]). The de-
cision tree algorithm C5.0 arose from further development of C4.5 and is
only available on a commercial basis. The time complexity of decision tree
induction is O(M × log(M)) [WF00].
Recently, an ensemble method called random forests was developed [Bre01].
The idea behind random forests is to built an ensemble of decision trees with
random feature selection and to combine their predictions by majority vote.
Each tree is grown on a random sub sample of all cases that is drawn with
replacement from the data set. Furthermore, for each tree and each node the
best split is chosen among randomly selected features. Random forests show
a good generalisation performance but a lack of interpretability.
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Figure 2.9: Axis-parallel (A), piece-wise axis-parallel (B), linear (C) and non-
linear (D) classifier.
Nonlinear decision trees
Conventional decision trees can only learn piece-wise axis-parallel problems
(see Fig. 2.9). However, nonlinear decision trees can also be constructed.
One possible solution is to generate new features as combinations of existing
features and to include them in the learning process. This is similar to an
explicit transformation from the input space X to a feature space F.
Ittner and Schlosser proposed the use of original features, the squares of the
original features and all pairwise products of original features [IS96]. For a
two-dimensional input space, this leads to a features space of five dimensions:
x1, x2, x
2
1, x
2
2, x1x2. Note that this transformation is equivalent to the one
employed by a polynomial kernel of degree d = 2 (and a two-dimensional
input space).
Conventional decision trees are univariate, that means they use only one
continuous or discrete feature at each decision node. However, multivariate
decision trees employing multivariate linear or multivariate nonlinear decision
nodes are also possible. For example, nonlinear decision trees using a neural
network or an SVM at each node were proposed.
More generally, [YA01] suggested an omnivariate decision tree where at each
node a univariate, multivariate linear or multivariate nonlinear decision func-
tion is chosen according to a statistical test.
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2.5.2 Logic regression
Logic regression is a regression and classification method to construct clas-
sifiers with a good interpretability [RL03, KR05, KRLH01]. Formally, logic
regression fits a model f(x) = b0 + b1L1(x) + ... + bnLn(x) where Lj(x) is
any Boolean expression of binary feature vectors. A logic regression classifier
only uses one Boolean combinations of binary features: f(x) = L1(x).
A Boolean expression consists of binary features which are combined using
the following three operators:
• ∨ OR
• ∧ AND
• ¬ NOT
An example would be the expression:
L= (”aberration of MDM2” or ”aberration of B1143G9” or ”aberration of
B438N16” or ”aberration of CDK4”) or (”aberration of B443B14” and ”aber-
ration of B1007B5” and ”aberration of GliGli” and ”aberration of B112B19”).
This expression reflects differences between pleiomorphic and dedifferentiated
liposarcoma [FSW+02].
Boolean expressions can also be represented graphically as a logical tree (Fig.
2.10). Each element of this tree is a node and has either zero or two children
(sub nodes). A node without children is called a leaf and consists of a binary
features or its conjugate (negation of the feature). All other nodes comprise
operators (”
∨
” or ”
∧
”).
The evaluation of all possible Boolean combinations is intractable. Instead, a
stochastic search algorithm, simulated annealing [KGV83], is used. A draw-
back of this strategy is that stochastic search algorithms do not always find
a global optimum.
In brief, simulated annealing starts with one tree. A score is defined as the
misclassification accuracy of this tree. The tree is changed by a randomly
chosen operation (”move”). If the score of the new tree is higher than the
score of the old tree then this move is accepted. Otherwise, the move is only
accepted with a probability depending on the score of the two trees and an
internal parameter of the annealing algorithm (temperature).
Possible operations (”moves”) are:
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Figure 2.10: And-or-tree representing differences between pleiomorphic and de-
differentiated liposarcoma.
• Exchange of two leaves
• Exchange of an operator (”and”, ”or”)
• Growing and pruning (at any node that is not a leaf)
• Growing and pruning (at any leaf)
Neighbours of logic expressions are defined by the number of moves according
to this list. Note that any logic expression can be reached from any other
logic expression in a finite number of steps.
The model complexity is defined as the (maximum) number of leaves and
should be chosen according to a cross-validation or a validation data set.
Another approach proposed by the authors for model selection is a permu-
tation test.
2.6 Discussion
In principle, two different kinds of constructive learning algorithms can be
considered.
A Construct a machine with a given complexity and minimise the empi-
rical risk. This principle is implemented in artificial neural networks
and logic regression.
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B Construct a machine with a given empirical risk (e.g., zero) and mini-
mise the complexity. This principle is used in support vector machines
and boosting.
For the first type of learning machine, a search over different complexity
classes (e.g., number of hidden neurons or number of trees) has to be im-
plemented to avoid overfitting. In the presence of noise, the second type of
learning machine requires the optimisation of a regularisation parameter C.
Support vector machine classifiers offer a good generalisation ability, both
from the empirical and theoretical point of view. SVMs are also univer-
sal approximators and can therefore learn any reasonable decision function
up to a desired accuracy. In conclusion, they are a good choice for many
classification problems.
Three problems remain:
• The appropriate choice of a similarity measure / kernel for a given
classification problem is critical. Even if the resulting support vector
machine with this kernel represents a universal approximator, this does
not necessarily lead to a large margin [HG03].
• A support vector machine classifier does not reveal explanatory rules.
• The complexity of the learning algorithm is approximately quadratic.
Convex boosting algorithms like Adaboost* were not tested in this thesis due
to the fact that no implementation was (publicly) available.
Other classifiers may be the first choice if the training set is very large or
includes many missing values. An example of classifiers that perform well
despite of missing values are decision trees. Large data sets require algorithms
with linear training time complexity like sparse grids [GGT01, GG02].
In the need for explanatory rules, classifiers like decision trees or logic regres-
sion seem to be appropriate.
Machine learning involves the search through a space of available decision
functions (hypotheses). The goal is to find the simplest hypothesis that fits
the available data and prior knowledge. Problems directly derived from this
definition that were raised in the introduction are:
1 What is the function space / space of available hypotheses?
2 What is a useful search strategy?
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3 How can the quality of the fit between data and hypotheses be estima-
ted?
4 How can the simplicity/complexity of a hypothesis be assessed?
The function space of the classifiers under investigation consisted of
• univariate decision functions (stumps: decision trees with one node)
• piece-wise axis-parallel decision functions (decision trees)
• multivariate linear decision functions (linear discriminant analysis)
• multivariate nonlinear decision functions (SVMs, neural networks, boos-
ting)
Search strategies are
• global optimisation (SVM, boosting)
• local greedy search (decision trees)
• stochastic search algorithms / simulated annealing (logic regression)
• exhaustive search (search for best parameter C of an SVM)
The fit between data and hypotheses can be estimated using different loss
functions like L1, L2, Lǫ and L0/1. Different loss functions lead to different
learning machines.
The complexity of a hypothesis can be estimated by the VC-dimension or
the minimum description length.
Chapter 3
Genomic profiles
3.1 Genomics and cancer
3.1.1 Cancer
Cancer is a disease characterised by unlimited cell division, independence
from cellular control and invasiveness of cells [HW00]. If a population of
tumour cells (a neoplasm) remains confined and does not metastasise or
invade neighbouring tissues, it is called a benign (noncancerous) neoplasm;
otherwise, a malignant (cancerous) neoplasm. Metastasis is a process by
which tumour cells escape their local environment, invade their surroundings,
penetrate lymphatic and blood vessels, migrate to remote sites and establish
new loci of growth elsewhere in the body. Cancer is a disease of animals and
humans, whereas benign tumours also occur in plants [DH96].
The development of tumours, called tumorigenesis, appears to be caused by
the combination of activating (genomic) alterations in proliferation-stimulatory
genes (oncogenes) and repressing aberrations in proliferation-inhibitory genes
(tumour-suppressor genes) [LKV98, Pop00]. These aberrations can be inhe-
rited via the germline or occur spontaneously [BGP03].
Oncogenes promote cell growth, cell division and angiogenesis (the growth
of new blood vessels) and can be identified in tumours by amplification, by
over-expression of their transcript or protein and by activating translocations
or mutations. Many oncogenes encode growth factors or growth factor recep-
tors (e.g., EGFR, VEGFR). Oncogenes are often carried by viruses (prefix v,
example v-ras). Their cellular counterparts are called proto-oncogenes (pre-
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fix c, example c-myc). Proto-oncogenes become activated through genomic
changes such as translocations, insertions and amplifications [Lew00].
Tumour suppressor genes inhibit cellular growth, repress cell-division, inhibit
metastasis or induce apoptosis (programmed cell death). They are typically
lost or damaged in cancer cells. A loss of one copy of a tumour suppressor
gene, either the one contributed by the mother or the one contributed by the
father, is called loss of heterozygosity of this gene (LOH, see 3.5). LOH of
tumour suppressor genes in cancer cells is often associated with an inacti-
vating point mutation of the remaining copy of the gene. This leads to loss
of function of the protective gene products. Examples of tumour suppressor
genes are the Rb and p53 gene. p53 is very important as it triggers the
activation of apoptosis and growth arrest pathways [Ore03].
Aberration patterns are strong prognostic markers in cancer patients and
can be used to define disease subtypes and predict response to therapy. A
close link between genomic instability and cancer progression exists. Fur-
thermore, different stages of tumour progression can be correlated with the
acquisition of specific genomic alterations. These range from point mutations
to deletions, insertions and chromosomal translocations. For tumour specific
aberrations see reference [VK04] for review.
Genomic aberrations also appear to play an important role for understanding
hereditary mental diseases (e.g., alcoholism, schizophrenia). However, this is
beyond the scope of this thesis.
3.1.2 Chromosomal aberrations
Humans and mice, like many other higher organisms, are diploid; they are
characterised by two sets of homologous chromosomes in each normal cell.
This is equivalent to a DNA copy number of two for each autosome (2 copies).
Humans possess 46 chromosomes (44 autosomes and 2 sex chromosomes),
whereas the diploid chromosome number of mice is 40.
Aneuploidy refers to a variation in chromosome number. A missing chro-
mosome from a diploid organism is called monosomy, whereas an additional
chromosome is called trisomy. Cells with higher chromosome numbers are
called polyploidic. More common examples are Turner’s syndrome, in which
females only have one X chromosome (XO); Klinefelter’s syndrome, in which
males have an extra X chromosome (XXY); and one variation of Down’s
syndrome, called trisomy 21, in which individuals have an extra chromosome
21.
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Variations in the arrangement of chromosome segments are called a translo-
cation. Broken chromosomes rejoin into nonhomologous combinations. An
inversion is characterised by a change in the order of segments within a chro-
mosome. The expression of a gene may be modified if it is translocated to
another chromosome (position effect). An example is the Philadelphia chro-
mosome, which is found in patients with chronic myeloid leukaemia (CML).
Here, an abnormally small chromosome 22 is caused by translocation of parts
of its genetic material to chromosome 9. This brings the abl oncogene from
chromosome 9 under the regulatory influence of the oncogene bcr on chro-
mosome 22, resulting in increased tyrosine kinase activity of abl.
Variations in the copy number of chromosomal segments can be summarised
as deletions, gains and high level amplifications. Loss of a chromosomal
segment is called a deletion. One extra segment of a chromosome is called
a gain and more than one a high level amplification. The amount of loss or
gain of genetic material can be quantified as copy number ratios, as described
later.
Finally, a genomic profile characterises all genomic aberrations in a given
sample or patient (Fig. 3.1).
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Figure 3.1: Genomic profile of a breast cancer tissue analysed in [SRS+06]. The
copy number ratios (y-axis) of all measurements (chromosomal fragments) are
ordered by their genomic position (x-axis). The x-axis depicts the chromosomes.
Note that each chromosome has a different length and the measurements are not
equidistant.
46 CHAPTER 3. GENOMIC PROFILES
3.2 Classical CGH
Classical comparative genomic hybridisation (CGH) is a well-established, mo-
lecular cytogenetic method, which allows the detection of chromosomal im-
balances in entire genomes [KKS+92, DMSJ+93, LJBL00]. This technique is
widely used in routine molecular diagnostics. Classical CGH has contribu-
ted greatly to our current state of knowledge regarding genomic alterations
in cancer (e.g.,[BHDM+95, BWD+96, MHM+01, RJB+02]). More than 150
new CGH studies were published in 2004 and referenced in Medline.
For CGH, test DNA (from the tumour) and reference (normal) DNA are la-
belled with different fluorochromes (test DNA red and control DNA green)
and co-hybridised onto metaphase chromosomes from normal cells. The
metaphase-chromosomes are acquired from the blood of a healthy donor.
Test and reference DNA compete for binding sites on the metaphase chro-
mosomes. The hybridisation probability depends on the relative DNA copy
numbers of test and reference DNA. When hybridising the two differently
labelled DNA on a normal metaphase spread, imbalances can be detected as
colour changes in chromosomes. The quantitative measurement of the colour
ratio profiles along each chromosome yields the DNA copy number differences
between sample and reference DNA. Digital image processing and analysis
are performed by commercially-available CGH analysis software.
The resolution of classical CGH for detection of chromosomal gains or losses
has been estimated in the range of 3-10 million base pairs [KGM+99, BPS+98].
CGH is unable to detect balanced translocations (translocations without
copy-number-changes).
Traditionally, CGH profiles have been evaluated according to the Internatio-
nal System for Human Cytogenetic Nomenclature (ISCN) [Mit95]. ISCN is
a formal language for describing DNA copy number changes, among others.
It covers low level gains (”rev ish enh”), high level gains (”rev ish ampl”)
and losses (”rev ish dim”). For example, loss of the chromosomal band 4p16
would be specified as ”rev ish dim(4p16)”.
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A
B
Figure 3.2: Sorted metaphases from a single normal (A) and tumour cell (B)
after hybridisation. All 20 mouse chromosomes are shown. Colours encode the
copy number ratios. The aberrations of chromosome 4 can be detected by visual
inspection. The respective copy number ratios are shown in Fig. 3.3. Figure taken
from a draft of [HGS+08].
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A
B
Figure 3.3: CGH profiles from a single normal (A) and tumour cell (B). All 20
mouse chromosomes are shown. The chromosomes are sketched in black, the copy
number ratios in blue and the thresholds for gains and losses as thin red / green
lines. Losses and gains are marked in red and green next to chromosomes and
could only be detected in tumour cells. Figure taken from a draft of [HGS+08].
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3.3 Matrix-CGH
More recently, conventional CGH has been further developed to increase ge-
nomic resolution [STLS+97, PSS+98, SNS+01, WLS+01]. Matrix-CGH (also
called array-CGH) is based upon array technology to detect genomic imba-
lances. In brief, an array of DNA fragments (e.g., BAC - Bacterial Artificial
Chromosomes) is immobilised on a glass chip. Each spot on this array re-
presents a unique DNA sequence or chromosomal locus. Genomic test DNA,
isolated from the tumour and reference (normal) DNA are labelled with dif-
ferent fluorochromes (e.g., Cy3 / Cy5) and mixed. The comparative geno-
mic hybridisation of test and reference DNA is performed against genomic
fragments, instead of using chromosomes as in conventional CGH. The fluo-
rescence signals for test DNA and control DNA are measured and correlated
to the copy number ratios of test and reference DNA (Fig. 3.5).
Finally, gains or losses of chromosomal material can be detected with a reso-
lution that is dependent upon the size and spacing of the immobilised DNA
fragments (Fig. 3.4). Typical resolutions are between 100 thousand base
pairs and 1 million base pairs. Note that one genomic fragment usually in-
cludes several genes. The average length of a BAC genomic fragment is 100
to 300 thousand base pairs, whereas the typical length of a gene is 10-15
thousand base pairs. Higher resolutions in the order of 50-100 thousand base
pairs are expected from oligonucleotide arrays [BZL+04].
Test DNA Control DNA 

(from tumour)
Matrix of arrayed
DNA fragments
balanced in test genome
gain in test genome
loss in test genome
Matrix-CGH
genomic
fragment
Figure 3.4: Screening of genomic imbalances using matrix-based comparative
genomic hybridisation.
50 CHAPTER 3. GENOMIC PROFILES
Figure 3.5: Matrix-CGH slide after hybridisation. Each spot belongs to one
measurement. This slide belongs to a case analysed in [SRS+06].
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3.4 Copy number ratios
The amount of loss or gain of genetic material within a genomic region can
be quantified as a copy number ratio. Each genomic region is covered by a
genomic fragment and this genomic fragment is used to determine the copy
number ratio within this region.
The copy number ratio equals one, when the chromosomal region is balanced
by two copies (diploid) of the reference DNA and two copies of the test DNA.
Expected copy number ratios of different aberration states are:
• 0 for a double loss (0 copies of test DNA)
• 0.5 for a single loss or monosomy (1 copy of test DNA)
• 1 for a balanced region without genomic aberrations (2 copies of test
DNA)
• 1.5 for a single gain or a trisomy (3 copies of test DNA)
Higher copy number ratios characterise higher degrees of amplification. Ho-
wever, not more than 8 copies are usually observed.
Finally, from a theoretical point of view, the distribution of log-2 copy number
ratios may be modelled as a mixture of a normal distribution of balanced copy
number ratios, a normal distribution of losses and a normal distribution of
gains (Fig. 3.6A).
Copy number ratios from real measurements differ from theoretically ex-
pected copy number ratios (Fig. 3.6C). Variations from theoretical copy
number ratios may be caused by a mixture of tumour and stromal cells, am-
plification (PCR) failures, inhomogeneous tumour samples and experimental
artefacts. Inhomogeneous tumour samples consist of different clones with
different aberration patterns. Mixtures of tumour and non-tumour-tissues
can often be resolved using microdissection, a labour-intensive technique by
which individual tumour cells are captured under a microscope.
It is interesting to note that an amplification protocol exists that reveals the
genomic content of one single (tumour) cell [KSKS+99]. This protocol was
used in two studies which are analysed in this thesis [HGS+08, SMH+05].
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Figure 3.6: Quantile-quantile plot of copy number ratios.
(A) Q-Q plot of simulated ratios with a low variance.
Assumptions: 10% losses (log2 mean ratio: -0.5), 10% gains (log2 mean ratio: 0.5).
(B) Simulated Q-Q plot with a higher variance, estimated from case 19.
(C) Q-Q plot of measured ratios from a breast cancer case [SRS+06].
3.5. LOSS OF HETEROZYGOSITY 53
3.5 Loss of heterozygosity
Loss of heterozygosity (LOH) is characterised by loss of one DNA copy, that
copy having been contributed either by the mother or the father. Its occur-
rence in cancer cells is often associated with tumour suppressor genes, where
the remaining copy of the gene can be inactivated by a single point mutation
[BGP03, OH00].
The detection of LOH is an experimental method to find deletions of genetic
material with a high resolution. A test of LOH can only be performed if
a given patient or organism is informative (heterozygous) at a given locus
in normal cells. This means that this patient or organism possesses two
different copies of DNA (alleles) at this locus, one from the father and one
from the mother. If the patient/organism has a constitutional homozygosity
(two identical copies, one from each parent), this method cannot be used at
this locus.
LOH is identified if an informative patient has heterozygosity at a given
locus in normal cells (e.g., blood cells) and an absence of heterozygosity at
this locus in tumour cells. In brief, the amount of DNA from each allele from
normal cells is compared with the amount of DNA from each allele in tumour
cells.
To minimise non-informative measurements, polymorphic markers (microsa-
tellites and single nucleotide polymorphisms (SNPs)) are used. A polymor-
phism is a DNA sequence alteration with at least two different alleles at a
locus in a population, where the frequency of the most common allele is less
than 99%.
3.6 Gene expression profiles
Although this thesis deals with genomic profiles, we will shortly discuss gene
expression profiles, as many methods can be utilised to assess both genomic
and gene expression profiles.
Gene expression profiles reflect the status of RNA transcripts (the first major
step in protein synthesis) in cells and tissues. The target probe is messenger-
RNA (m-RNA) instead of DNA for genomic profiles. m-RNA is isolated
from tumour and control cells, reversely transcribed to cDNA (complemen-
tary DNA), labelled with two different fluorescent dyes and co-hybridised to
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complementary probes. Finally, the fluorescence intensities reflect the rela-
tive expression value.
3.6.1 DNA microarrays
cDNA microarrays or oligonucleotide microarrays can be used to measure the
expression of thousands of genes in a single experiment. Briefly, an array of
DNA spots, namely genomic DNA fragments or oligonucleotides, is attached
to a (glass) chip. The labelled cDNA is then co-hybridised against these
DNA spots.
3.6.2 CESH
Comparative expressed sequence hybridisation (CESH) is a technique that re-
veals gene expression patterns according to chromosomal locations, in a man-
ner similar to the way in which CGH detects copy number changes [LWC+01,
LWW+03, GWHMR+04, VDWPW04]. In brief, reverse-transcribed test and
reference RNA are differentially labelled and co-hybridised to normal meta-
phase chromosomes. The resolution of CESH is low compared to microarray
gene expression arrays but no prior sequence information of genes or cloning
is required. Furthermore, CESH can be performed by using existing CGH /
fluorescence in situ hybridisation expertise, equipment and software.
3.6.3 Comparison of genomic profiles with gene ex-
pression profiles
The features of genomic profiles are genomic fragments, whereas the features
of gene expression profiles are EST (expressed sequence tags) or cDNA clones.
Consequently, the feature values of genomic profiles are copy number ratios,
whereas the feature values of gene expression profiles are gene expression
ratios.
One noteworthy difference between genomic profiles and gene expression pro-
files is the importance of local correlation patterns of copy number ratios.
Genomic aberrations often affect not only single genes, but also larger re-
gions or even entire chromosomes. The correlation between copy number
ratios of adjacent genomic fragments therefore is higher than the correlation
of gene expression ratios of adjacent genes.
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Another difference is that the normal state of genomic profiles is known (2
copies) whereas the normal expression profile of normal cells differs with
respect to the cell type and metabolic condition of the cell.
In addition, copy number ratios above or below a threshold have a clear
biological meaning (gain, loss, or balanced). Defining such a threshold is
much more difficult for gene expression ratios.
3.7 Therapeutic interference points
The final goal and an immense challenge of cytogenetic cancer research is
the development of specific anticancer drugs. Such drugs should inhibit the
growth-stimulatory activity of oncogene proteins and reactivate the growth-
inhibitory effect of tumour-suppressor proteins. Targeted anticancer drugs
should have a higher level of efficacy and specificity and fewer side effects
than cytotoxic drugs currently used.
Examples of such drugs are the kinase inhibitor Gleevec and the monoclonal
antibodies Rituxan, Herceptin and Avastin [HZ03].
Gleevec (imatinib mesylate) inhibits a family of tyrosine kinases and is in
clinical use for treatment of chronic myelogenous leukaemia (CML) and gas-
trointestinal stromal tumour(GIST) patients [Saw03]. This kinase inhibitor
targets the activation of a protease through fusion (CML) and by activating
point mutations (GISTs).
Avastin is an anti-angiogenesis agent currently being used in metastatic co-
lon cancer patients [IL04]. Herceptin (trastuzumab) targets the HER2/neu
oncogene in breast cancer patients [RRB+01]; Rituxan (rituximab) the CD20
gene of patients with non-Hodgkin’s lymphoma [CLB+02]. Many other drugs
are in the developmental stages (e.g., [Hor04, Saw03]).
At this point bioinformatics comes into play. Cancer is a heterogeneous
disease and specific therapies will only cure a subgroup of patients. The
identification of such a responder subgroup for each new drug is a prerequisite
for clinical success.
Moreover, even with specific anticancer drugs, a major challenge of cancer
treatment is tailoring the appropriate therapy for a specific patient. Rituxan,
for example, is patient-specific administered as a single therapy or in combi-
nation with chemotherapy.
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Chapter 4
Workflow for machine learning
of genomic profiles
4.1 Introduction
In this chapter, a machine learning strategy for detecting aberration patterns
associated with a particular tumour type or disease state is proposed. Two
important aspects of such a workflow are a multi-resolutional analysis and
an automatic assignment of aberrations.
Traditionally, genomic and gene expression profiles are analysed by machine
learning without considering the local correlation pattern of the measure-
ments. Here, I discuss ideas for a multi-resolutional analysis of genomic
profiles.
Copy number ratios reveal genomic alterations, i.e. gains and losses. It seems
therefore appropriate to discretise copy number ratios. The challenge here
is to find optimal thresholds that define genomic aberrations and separate
different (tumour) classes.
Genomic profiles are often incomplete. The machine learning community
uses basic methods for handling missing values (e.g., [WF00]) only. In this
chapter, I discuss methods for imputing missing values that are motivated
by statistics and the biology of genomic profiles.
In addition to traditional issues of machine learning, I also consider the task
of explaining the results derived from machine learning to a user who might
not be familiar with this field. This includes a case-based analysis of the
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classification, an estimation of the classification certainty and the competence
of the classifier.
The workflow focuses mainly on support vector machines (SVMs) and deci-
sion trees as classifiers. Several similarity measures / kernels are compared
with regard to their applicability for genomic profiles.
Finally, the workflow includes the following steps (Fig. 4.1):
1 Data preprocessing and feature selection
• Data preprocessing
• Handling missing values
• Multi-resolutional analysis
• Discretisation (assignment of losses and gains)
• Feature selection
2 Classifier design and evaluation
• Classifier selection
• Classifier adaptation
• Classifier assessment
3 Case-based analysis of a classification
• Qualitative explanation
• Competence estimation
• Classification certainty
My contributions are a preprocessing method for classical CGH data [STJE05],
a wavelet-based analysis of genomic profiles (presented as a poster at the
Gordon Research Conference on Molecular Genetics, July 18-23, 2004, Ox-
ford), a qualitative assessment of classifiers (presented as a talk at the 26th
annual conference of the German Classification Society (GfKl), July 22-24,
2002, Mannheim), an explanation component for classification algorithms
[SMF+03] and the workflow itself (not yet published).
The idea of the classical CGH preprocessing was conceived in cooperation
with Stefan Joos. I programmed a prototype and supervised the final im-
plementation by Bernhard Tausch. The imputation strategy in section 4.2.4
was developed together with Daniel Stange.
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The explanation component was also discussed in a diploma thesis by Jasmin
Mu¨ller [Mu¨l02], which I supervised.
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Figure 4.1: General workflow for machine learning of genomic profiles as sugges-
ted in this chapter.
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4.2 Data preprocessing and feature selection
The preprocessing of data sets is the first step in a successful data mining
workflow [WF00] and includes
• Quality-control of the data (filtering)
• Handling missing values and
• Multi-resolutional preprocessing.
The specific preprocessing steps depend on the type of genomic profile and
the data set. Important characteristics of each type of genomic profile are
summarised in table 4.1.
Profiletype Dimen-
sionality
Discrete /
Continuous
Missing
values [%]
Local spa-
tial correla-
tion
LOH <200 Discrete 40 % Yes
CGH 100 - 300 Discrete or
continuous
< 5 % Yes
Matrix-
CGH
300 - 10.000 Continuous
or discrete
< 5 % Yes
Table 4.1: Short description of the different types of genomic profiles. The high
number of missing LOH values is caused by non-informative measurements. CGH
and matrix-CGH-profiles can be analysed as discrete or continuous profiles. Dis-
crete genomic profiles consist of ordinal measurements (loss < balanced < gain).
The percentage of missing values of CGH data depends on the inclusion or exclu-
sion of measurements from error-prone regions (e.g. centromeres). All numbers
were estimated by the author of this thesis. A local spatial correlation between
the measurements characterises all genomic profiles.
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4.2.1 Preprocessing of classical CGH data sets
Program CGH-profiler
Chromosomal imbalances detected by classical CGH are described in a com-
plex syntax based on the International Standard for Cytogenetic Nomen-
clature (ISCN, [Mit95]). For example, loss of the chromosomal band 4p16
would be specified as ”rev ish dim(4p16)”. This semantic description of chro-
mosomal imbalances hinders a large-scale statistical analysis across different
experiments, e.g. for finding aberration patterns associated with a particular
disease type or state.
Together with Bernhard Tausch and Stefan Joos, I therefore developed the
program CGH-profiler, which circumvents the ISCN nomenclature by auto-
matically assigning a mean (or median) copy number ratio to each chromo-
somal band. Finally, this is the basis for an automatic assignment of losses,
gains and high-level gains.
CGH-Profiler imports data from different CGH system vendors and directly
transfers the data into a table format that is readily accessible for subsequent
statistical analysis. CGH-profiler comes with different consistency checks,
calculates various statistics and automatically assigns a mean (or median)
copy number ratio to each chromosomal band. Import of CGH profiles from
different CGH system vendors is already supported; its extension to other
systems can be readily achieved through Perl scripts.
CGH profiler can also be used to analyse comparative expressed sequence hy-
bridisation (CESH) data. CESH reveals gene expression patterns according
to chromosomal locations in a similar manner as CGH detects chromosomal
imbalances (see section 3.6.2).
I compared losses and gains automatically detected by CGH-profiler with
those described by conventional CGH analysis (encoded in ISCN) for two
data sets (data not shown) and found a high degree of accordance. Notably,
conventional CGH evaluation often characterises large regions as gain or loss
whereas the ratio value, as determined by the programme CGH-profiler, is
only altered in part of the entire region.
Data mining of CGH profiles requires a matrix representation of those pro-
files. An alternative to my approach is an ISCN-to-matrix parser [BC01].
Such a parser is useful for large repositories of CGH studies (e.g., www.
progenetix.net, providing more than 10818 cases from 383 publications).
However, a direct transformation of profile values to a matrix representation
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Figure 4.2: Workflow for analysing classical CGH profiles using the program
CGH-profiler. CGH-profiler translates CGH profiles into a table of profile values
which can be further used for data mining tasks like classification and clustering.
Historically, CGH-profiles are encoded using the ISCN syntax.
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is more efficient.
The program CGH-profiler has only been used for CGH-analysis in humans
so far. An extension to CGH profiles in other species can be easily achieved
by adopting the mapping file used for band assignments.
Implementation and usage
CGH-profiler deals with genomic profiles of classical CGH data sets. Here,
a profile value is a measurement of a given biological case, a chromosomal
location and a hybridisation (to a specific metaphase). Each hybridisation
can be considered as a repeat (of the measurement). The number of profile
values of each chromosome corresponds to the length of this chromosome.
The program CGH-profiler includes the following processing steps:
• Conversion of CGH profile values to a meta format independent of the
used CGH system
• Profile cleansing, consistency check of the chromosomal length
• Interpolation to a given length (adjustable, e.g., 128 points per chro-
mosome) by using cubic (Akima) splines
• Calculation of median copy number ratios from all hybridisations (re-
peats) of a given case
• User defined exclusion of certain regions (centromeres, telomeres, tu-
mour specific bands)
• Assignment of mean (or median) copy number ratios to chromosomal
bands
The calculation of median copy number ratios from all hybridisations is equi-
valent to combining repeated measurements. Here, the median is used to deal
with outliers. The assignment of mean (or median) copy number ratios to a
chromosomal bands can be considered as a reduction of the resolution. Ho-
wever, the reason behind this step is to calculate a number with a biological
meaning. The choice of the mean or median takes the user of the program.
The CGH profile values must be exported from a commercial CGH sys-
tem. To become independent of the particular CGH system, the exported
profile values are then transformed to a meta format using a Perl script.
The resulting meta format file includes all profile values of all cases for all
chromosomes. The parsing and transformation of CGH profile values from
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two popular CGH systems, namely CytoVision (Applied imaging, http:
//www.appliedimagingcorp.com/) and Isis CGH (Metasystems, http://
www.metasystems.de), are supported. Profiles from other CGH system ven-
dors may be integrated using adapted Perl scripts.
A consistency check of all profile values is performed to exclude wrongly
assigned profiles. All profile measurements of a chromosome are excluded
from further analysis if the difference between the length of the profile and
the mean length of the respective type of chromosome is larger than a user
defined threshold (e.g. 15%).
The remaining profile values of a chromosome are interpolated to a new
profile of a given length. This is a prerequisite for a consistent merge of all
measurements. I used cubic Akima and Fritsch/Carlson splines (polynomials
of degree 2) for this interpolation implemented in the matpack library (http:
//www.matpack.de). The number of interpolation points can be defined by
the user, the predefined value is 128. The number 128 is optimal for the
subsequent signal processing using wavelets.
From all profiles of a given case and chromosome, the median or mean copy
number at each interpolation point is calculated. The choice of median or
mean is optional to the user.
The CGH measurements of some chromosomal regions (e.g. those containing
a large number of highly repetitive sequences) are not reliable [KKP+94],
especially after PCR (polymerase chain reaction) amplification of the geno-
mic DNA. The measurements of certain regions should therefore not be used
for an automatic analysis. According to the expert knowledge of Dr. Stefan
Joos, all centromeres, some telomeric regions, chromosome 19 and the sex
chromosomes are excluded. However, the user can specify all critical regions
in a configuration file. The ratios of all excluded regions can be marked as
NA (value not known) or balanced.
The mean or median profile of each case and chromosome can be mapped to
an ISCN-400-ideogram (schematic chromosomal representation) without sub-
bands [Mit95] so that a single mean value is assigned to each chromosomal
band. The predefined mapping file is based on the ISCN-400-ideogram and a
resolution of 128 interpolation points. E.g., band 1p36 is located from 1/128
to 13/128 on an ideogram. The mean value of this band is therefore the mean
of the profile values 1,..,13. This data representation is the starting point for
further analysis. Using threshold values the medium copy numbers can be
readily translated into semantic expressions, namely losses (threshold <0.75),
gains (threshold >1.25), high level gains (threshold >2) and balanced.
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This CGH-preprocessing method has been published [STJE05] and can
be downloaded from http://www.dkfz-heidelberg.de/ibios/archive/
ressources/CGHProfiler.
4.2.2 Preprocessing of matrix-CGH data sets
The fluorescence signals for test DNA and control DNA are measured by a
scanner (e.g., Axon 4000B scanner, Axon Instruments, Burlingame, USA).
An example of a resulting image is given in Fig. 3.5 (chapter 3). Note, that
some spots (encircled measurement areas) are disturbed by dirt, spotting
errors and hybridisation failures. Each slide is therefore manually checked
by the experimenter. This process is supported by an automatic filtering of
spots (measurements) without errors. See also section 4.2.4.
Filtering
Filtering criteria are
• Ratio of intensity and local background (e.g., lower threshold 3 for
inclusion)
• Ratio of mean and median intensity of a spot (e.g., upper threshold 1.3
for inclusion)
• Standard deviation of duplicates (repeated measurements, e.g, upper
threshold 0.25 for inclusion)
Finally, spots with errors are marked and excluded from further analysis.
Spots that have errors for just a few cases are treated as missing values.
Normalisation
A normalisation procedure corrects for systematic spatial or intensity biases.
Here, the same principles apply as for normalising cDNA-microarrays [Itt05]
and a good choice is a block-wise normalisation by Loess [BIAS03].
Duplicate treatment
Each genomic fragment is generally spotted in several copies. This is equi-
valent to a repeated measurement and enables a statistical assessment. The
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standard deviation of all duplicates is used as filtering criteria (as stated be-
fore). Finally, the copy number ratio of a genomic fragment is calculated as
the median value of all included measurements (from a given sample).
Assignment of chromosomal mappings
Each genomic fragment represents a segment of the DNA and is characterised
by its chromosomal position (in kilo bases). However, due to the on-going
sequence analysis of the genome this chromosomal position was often uns-
table. Therefore, a re-assignment of the chromosomal position of all genomic
fragments at the time of the analysis was necessary. However, for future
applications of this workflow (and fully sequenced genomes) this step should
no longer be necessary.
State-of-the-art in identifying genomic aberrations
Genomic aberrations often affect not only single genes, but also larger regions
or even entire chromosomes. Subsequently, methods were developed that re-
cognise regions with approximately the same copy number ratio. Some me-
thods return the position of a region only, whereas others try to characterise
a region as loss, balanced or gain (Fig. 4.3). However, all methods assign
the same copy number ratio to all fragments within a region of a case.
Examples are:
GLAD (based on adaptive weights smoothing) [HST+04] Glad esti-
mates the breakpoints of piecewise constant functions. Each piecewise
function is fitted by the adaptive weights smoothing procedure. The
number of breakpoints is determined by a penalised likelihood. Glad
returned biologically meaningful regions for the data analysed. Fur-
thermore, Glad could also assign losses and gains to each region using
a clustering algorithm. However, the provided assignments were not
always biologically reasonable (according to biological experts) and fi-
nally not used.
aCGH (based on a Hidden Markov Model) [JMM+04] Jong et al
suggested a Hidden Markov Model, where each state represents one
region with similar copy number ratios. The transition probabilities
are the copy number differences between two regions. The number of
breakpoints is calculated by the AIC (Akaike Information Criterion).
4.2. DATA PREPROCESSING AND FEATURE SELECTION 67
DNAcopy (based on circular binary segmentation) [OVLW04]
This method recursively splits genomic profiles into two or three
segments with equal copy numbers. A split is performed iff the
t-statistic of the split is higher than the t-test statistics of a random
split. The method stops if no further split is meaningful.
Smith-Waterman dynamic-programming [PRM+05] This algorithm
is based on the Smith-Waterman dynamic programming. It selects
regions where the copy number ratios of adjacent genomic fragments
are above (below) a threshold t. The selection of t is crucial. Price
suggested the use of the difference between a male and a female hybri-
disation (at the y-chromosome) as a first guess. Next, a permutation
test of each region is performed and regions without significance are
removed. This methods seems to be appropriate for mental disorders
and germline aberrations. However, for tumour profiles it is intractable
due to their high number of aberrations.
CLAC (clustering along chromosomes) [WKP+05] is a clustering ap-
proach to detect chromosomal losses and gains. Briefly, an agglomera-
tive clustering algorithm is used for each chromosomal arm. Subtrees
representing gains or losses are selected according to the size of the
subtree, the differences of the copy number ratios at the edges of the
subtrees and the average copy number ratio of the subtree. Finally,
a false discovery rate (FDR) is calculated according to the number of
genomic fragments selected in a tumour and a normal (control) case.
Problems with this method are the unstable implementation and the
required normal-normal (control) hybridisations.
Hot spot detection using the fused lasso [TW07] is based based on
the lasso, a penalised regression algorithm. The constraints of the lasso
are estimated based on the mean and the median absolute deviation of
smoothed genomic profiles (using lowess).
In the end, I used Glad for estimating the change points of genomic pro-
files (but not for the assignment of losses and gains). As two reviews
[LJKP05, WF05] recently revealed that DNAcopy may outperform Glad,
future applications should consider DNAcopy.
4.2.3 Preprocessing of LOH data sets
A special preprocessing of LOH data sets is not necessary.
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Figure 4.3: Identification of copy number changes. Each cross depicts one mea-
surement, the x-axis the chromosomal positions and the y-axis the copy number
ratios. Some algorithms detect the edge of a copy number change only (A), whe-
reas other algorithms additionally assign gains and losses. Measurements that were
detected as chromosomal gains are visualised as green wide crosses (B).
4.2.4 Handling missing values
Reasons for missing values are often experimental errors like irregularities
in the production and detection of spots, dirt and scratches on the slides,
inhomogeneous hybridisation and low signal-to-noise ratios. Measurements
with a high variance of all replicates are excluded and therefore also lead
to missing values. Figure 3.5 (chapter 3) shows some of these errors for a
matrix-CGH data set.
The distribution of missingness can be divided into [SG02]:
• Missing at random (MAR),
• Missing completely at random (MCAR) and
• Missing not at random (MNAR).
Missing at random occurs when the distribution of missingness does not de-
pend on the (true) feature values of missing data. However, ”MAR allows
that the probability of missingness depends on observed but not on missing
data” [SG02]. If the distribution of missingness depends on missing data,
then the distribution of missingness is called missing not at random. Missing
completely at random means that the distribution of the missingness does not
depend on observed or missing data and is a subtype of MAR. Most impu-
tation algorithms require MAR. However, the distribution of missingness for
array-CGH data is sometimes MNAR. The higher probability of missingness
of lower copy number ratios is caused by a lower signal-to-noise-ratio.
Generally, the following strategies to deal with missing values are possible:
• Complete-case-analysis
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• Imputation of missing values
• Model estimation with missing values
Complete-case-analysis
In a complete-case-analysis, all cases with at least one missing feature value
are discarded and the analysis is based on complete cases only. If the dimen-
sionality of the data set is high, this strategy will dramatically reduce the
number of available cases. A complete-case-analysis is reliable for a MCAR
distribution only and therefore should not be applied if the probability of mis-
singness is related to any feature or the class identifier. The bias introduced
by a complete-case-analysis may be reduced by re-weighting the remaining
complete cases according to the distribution of all cases or the population.
For genomic profiles, the complete-case-analysis method is not applicable due
to the high dimensionality of the data sets. Most of the cases suffer from at
least one missing value and would therefore be discarded. Imagine a data set
with 300 genomic fragments and 1% missing values. A complete-case-analysis
would discard (1− 0.99300) = 95% of all cases.
After all, I used a complete-case-analysis for cases with missing class labels.
That is to say, all cases with missing class labels were discarded.
Imputation
Imputation strategies discussed in the literature comprise [SG02]:
• Single imputation
• Multiple imputation
• Maximum likelihood estimation
Single imputation replaces a missing item with one plausible value, whereas
multiple imputation replaces it with many (different) values. Maximum li-
kelihood estimates missing values according to a parametric model of the
observed data.
Single imputation includes the following strategies [SG02]:
• Imputing univariate means
• Imputing from univariate distributions
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• Imputing conditional means
• Imputing from conditional distributions
The replacement of missing values by the mean (median) value of the corres-
ponding genomic fragment is a strategy commonly used. However, it reduces
variances and neglects covariances. Discrete genomic profiles (classical CGH)
can only be replaced with the median. Yet, the median is almost always the
balanced situation and therefore a ”safe” strategy at the expense of the power
to detect differential aberrated genomic fragments.
Imputing from univariate distributions means that a missing value of genomic
fragment xm is replaced by a random sample of all observed values x1, ..., xn
for this genomic fragment x (hot deck) or from a parametric model of the
distribution. This method also neglects correlations. Moreover, it may insert
genomic aberrations in balanced regions and is consequently not discussed
further.
Imputing from conditional means is often based on regression methods. The
values of the missing values are estimated using a regression model based
on other genomic fragments or samples. This method can be applied only if
a correlation structure within the data set exists. Regression models based
on linear regression [SAG+05], k-nearest neighbour [TCS+01], SVD (singu-
lar value decomposition) regression [TCS+01] and support vector regression
[WLJF06] have been successfully applied to gene expression data. These me-
thods could also be used to estimate missing values of continuous genomic
profiles. For discrete genomic profiles, classification methods like k-nearest
neighbour, support vector machines or random forests could be applied.
Joernsten et al. proposed a regression model that combines different im-
putation methods [JWWO05]. The weight of each imputation method is
calculated using a simulation strategy. Briefly, a given data S set is imputed
using the k-nearest neighbour method leading to a new data set S ′. Thereaf-
ter, missing values for this data set S ′ are generated with the probability of
missing values in the original data set S. This process is repeated 20 times
and generates 20 new data sets S1 to S20 with artificially missing values.
Moreover, it is required that the missing values of S1 to S20 are distinct from
the originally missing values of S. Each imputation method is assessed given
the difference between imputed values of S1 to S20 and the original values of
S. Finally, the weight of each imputation method is determined according to
its performance. The drawback of this method is the computational effort.
Imputation from unconditional distributions is based on a conditional distri-
bution of missing values given the observed values. The missing values may
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be replaced by a regression prediction plus a residual error drawn from a
normal distribution. Imputing from a conditional distribution almost always
leads to unbiased estimates under MAR.
A drawback of single imputing is that the uncertainty about missing values
is not taken into account in the analysis after the imputation. This leads to
an underestimation of the variance.
The underlying idea of multiple imputation is to replace a missing value by
many (≥ 2 and typically ≤ 10) plausible values [BLS06]. Multiple imputing
reflects the uncertainty about a missing value. First of all, each missing value
is replaced by a member of a distribution of plausible values for this missing
value. This process is n times repeated. Thereafter, each replaced data set is
independently analysed. Finally, all analyses are combined. For a scalar, the
combined estimate is just the average whereas its variance is calculated as a
modified sum of the variances within each analysis and the variance between
all analyses.
Commonly used regression-based multiple-imputing methods are:
• Bayesian least squares
• Predictive mean matching
• Local random residuals.
Bayesian least squares draws the values of missing values from a linear regres-
sion plus normal distributed random noise with appropriate residual variance.
Multiple values are drawn for each missing value. If more than one value per
case is missing, then a multi-variate regression and a joint normal model has
to be employed.
Predictive mean matching estimates all values (missing and observed) from
a case xm with missing values according to a linear regression plus normal
distributed noise. Thereafter, the case xc that is closest to these predicted
values is determined. The missing values of xm are replaced by the observed
values of this closest case xc. This process is repeated multiple times.
Local random residuals uses a linear regression to predict all values (missing
and observed) of a case with missing values. Thereafter, the K most simi-
lar cases are determined. One of these cases is randomly chosen and called
xc. The missing values of xm are replaced by the predicted values of xm.
Furthermore, the residuals from the randomly chosen case xc (predicted va-
lues x̂c minus observed values xc) are added. This replacement algorithm is
applied multiple time using different regression estimates.
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Biologically motivated imputation strategy
Given the correlation structure of genomic profiles, missing values can be
imputed using the copy number ratios of genomic fragments adjacent to the
missing value. Nevertheless, the measurements considered should be restric-
ted to the same chromosomal arm. Measurements from two different telo-
meres (chromosomal ends of two different chromosomes) are not correlated,
even though they are next to each other in a matrix representation of the
data set.
For discrete genomic profiles, an imputation strategy is as follows (Fig. 4.4):
• A missing value is imputed by an amplification iff all six measurements
next to it are amplifications and belong to the same chromosomal arm.
• A missing value is imputed by a deletion iff all six measurements next
to it are deletions and belong to the same chromosomal arm.
• Otherwise, the missing value is imputed by assuming a balanced mea-
surement.
The size of the kernel (number of neighbours; six in the previous example)
depends on the resolution of the array and the signal-to-noise-ratio.
Model estimation with missing values
Model estimation with missing values is based on algorithms that can cope
with missing values. Examples are decision trees [Qui93] or a special imple-
mentation of support vector machines [PDBSDM05] using an adapted loss
function. As no implementation of this SVM was publicly available, it was
not applied in this thesis.
Quinlan compared different methods of decision trees to deal with missing
values [Qui89]. A simple but effective strategy of decision trees to deal with
missing values is to use surrogate splits. A missing value is replaced by the
value from the attribute with the most similar partitioning (of all cases).
More advanced methods explore all subtrees of a node with a missing value
and calculate the probabilities of different class assignments. For the induc-
tion of the tree, missing values are not considered while calculating the splits,
but the information gain is adapted accordingly.
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Figure 4.4: Imputation of discretised genomic profiles motivated by their bio-
logical correlation structure. The missing value (question mark) is replaced by a
deletion iff all observed values are deletions too (B). Otherwise, it is replaced by a
balanced measurement (A).
Conclusion
Based on the theoretical considerations presented before, the following me-
thods to deal with missing values of genomic profiles should be taken into
account.
Missing values of continuous genomic profiles can be imputed using
• mean values of adjacent values
• values estimated by a regression or classification method
Missing values of discrete genomic profiles can be imputed using
• median value (most often the balanced state)
• values estimated by a classification method
The imputation of LOH data sets seems not to be useful according to the high
number of approx. 40% not informative (missing) values. Therefore, robust
algorithms, that can deal with missing values, should be applied instead.
Finally, I used the following strategy to deal with missing values of genomic
profiles: If a feature or case included too many missing values it was excluded.
Features or cases with no more than 5 or 10% (depending on the data set)
missing values were imputed using the values of adjacent genomic fragments.
For LOH data, the decision tree algorithm C5.0 was applied without any
imputation.
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4.2.5 Multi-resolutional preprocessing
The combination of several copy number ratios of adjacent genomic fragments
decreases the resolution and enhances the reliability of the result. Single
gains and losses without support from adjacent genomic fragments can be
discarded as they often represent experimental errors or genomic fragments
with a wrongly assigned chromosomal position.
Ideas for a multi-resolutional preprocessing of genomic profiles include
• Moving average,
• Identification of segments with similar copy number ratios and
• Wavelets.
Alternative solutions to deal with the curse of dimensionality would have
been:
• Increasing the number of samples and
• Incorporation of previous knowledge.
Previous knowledge was used for excluding genomic fragments with a high
error rate (e.g., genomic fragments with cross-hybridisation problems). The
number of samples was always limited by the availability of tumour probes
and financial limits. For future applications of this workflow, higher genomic
resolutions will be possible due to increased sample numbers.
Moving average
The simplest algorithm is the combination of overlapping or adjacent mea-
surements using a sliding window approach. I used this method successfully
for the LOH data. The drawback of a moving average is that it does not
preserve the edges of aberrated regions.
Identification of segments with similar copy number ratios
More advanced methods detect chromosomal regions with similar copy num-
ber ratios and assign the same (estimated) copy number ratio to all measu-
rements inside a region. These methods were discussed in section 4.2.2.
After all and for continuous genomic profiles, I used the Glad algorithm that
searches for piecewise constant functions. For each detected region, it assigns
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the copy number ratio of an estimated piecewise constant to all measurements
inside this region.
Wavelets
One idea for a multi-resolutional preprocessing is based on a wavelet trans-
formation. Wavelets are mathematical functions that divide genomic pro-
files into different frequency components with a resolution adequate to their
scale. The wavelet transformation is a refinement of the Fourier transfor-
mation. The underlying idea of all transformations is that the transformed
representation of the data facilitates the analysis of the data.
Wavelets have been successfully applied for denoising of images, image com-
pression (JPEG2000), EEG (electroencephalogram) and ECG (electrocardio-
gram). Recently, wavelets have also been used for denoising of continuous
genomic profiles [HSG+05].
Mathematically, wavelets decompose a signal (a genomic profile) into a set
of basis functions [Mal99]:
Wf(u, s) =
∫ ∞
x=−∞
f(x)ψ∗u,s(x)dx. (4.2.1)
ψ∗u,s(x) are the complex conjugated basis functions. Each basis function is
called a wavelet, has a mean value zero
∫ ∞
x=−∞
ψu,s(x)dx = 0 (4.2.2)
and is generated from a basic wavelet (mother wavelet) by scaling (parameter
s) and translation (parameter u)
ψu,s(x) =
1√
s
ψ
(
x− u
s
)
. (4.2.3)
The simplest example of a (mother) wavelet function is a Haar wavelet:
ψ(x) =

1 0 ≤ x < 1
2
−1 1
2
≤ x ≤ 1
0 else.
(4.2.4)
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Figure 4.5: Chromosomal aberrations of high and low frequency are plotted
against an ideogram (schematic chromosomal map). A) Distinct chromosomal
regions: high frequency B) Large chromosomal regions: low frequency
However, I used the Daubechies wavelet family [Mal99] due to their compact
support. A closed formal representation of this family does not exist and
they are iteratively calculated by a filter bank approach.
The signal-processing terminology is based on the frequency of signals. How
is such a frequency defined for genomic profiles?
The frequency of a genomic aberration is determined by its length. Large ge-
nomic aberrations are equivalent to low frequencies whereas distinct genomic
aberrations have high frequencies (Fig. 4.5). Finally, each aberration can be
described one-to-one by its frequency (length) and location (in kB).
Fig. 4.6 shows a wavelet analysis of the cancer cell line HL60. The large
aberration of chromosome 5 is reflected by the wavelet coefficient of a low
frequency whereas the distinct aberration of chromosome 8 leads to a wavelet
coefficient of a high frequency. Please note that the spatial resolution of the
wavelet coefficient with a higher frequency is much better than the wavelet
coefficient of a lower frequency.
Due to the fact that the genomic fragments on the array-CGH chip are not
strictly equidistant, copy number ratios on (128) virtual equidistant genomic
fragments using an interpolation algorithm (splines) are computed (using the
algorithm described in section 4.2.1). This is a prerequisite for the application
of wavelets.
My idea was to use all wavelet coefficients above a given threshold as input
of a classifier. In retrospect, this approach did not outperform the use of
the original features (copy number ratios after a multi-resolutional prepro-
cessing).
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Figure 4.6: Wavelet analysis of the cancer cell line HL60. Genomic profiles of
chromosomes 5 (A) and 8 (B), their most important (Daubechies) wavelet compo-
nents on chromosome 5 (C) and 8 (D), and all wavelet coefficients on chromosome
5 (E) and 8 (F). The underlying matrix-CGH-measurements were kindly provided
by Bernhard Radlwimmer. All calculations were performed using the statistical
software package R and the wavethresh library.
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4.2.6 Discretisation and encoding of features
From a theoretical point of view, a simple discretisation algorithm, using a
threshold of 0.5 and 1.5 for losses and gains respectively, would be sufficient.
However, due to experimental noise and the fact that a mixture of normal
(e.g., stroma) and tumour cells is analysed, this approach is not possible.
Moreover, some tumour types may share a gain of genomic material but
could be still distinguished regarding the copy number ratio. By way of
example, one tumour type is characterised by a low level gain (copy number
ratio 1.5) and the other by a high level gain of chromosome 1q (copy number
ratio 2). Therefore, I propose two automatically chosen thresholds for the
discretisation of gains and losses.
One way to determine such discriminating thresholds would be to estimate
the classification accuracy of all possible thresholds. However, the computa-
tional effort of such a simulation (together with a model selection and a cross
validation) would have been intractable.
Therefore, I estimated both thresholds by means of statistics. Briefly, I calcu-
lated the number of discriminating genomic fragments (between two classes)
for each possible threshold. A genomic fragment was called discriminating iff
the number of deletions (for thresholds below 1) or amplifications (for thre-
sholds above 1) differed significantly (as measured by the Chi-square test or
the Fisher test). Furthermore, I calculated the same statistics 100 times for
all possible thresholds and permuted class labels. Next, I calculated the 95%
quantile of the number of discriminating genomic fragments for each pos-
sible threshold from the random experiments and compared it to the number
of discriminating genomic fragments from the original data (Fig. 4.7). Fi-
nally, I chose the threshold with the largest difference between the number
of discriminating regions in the data set and in the random experiments (as
determined by a Chi-square test).
I suggested and applied the described discretisation strategy together with a
feature selection (see below) in a study published in [SRS+06] and described
in section 5.2.1. In this study, I analysed the best threshold for gains in
the interval [1,3] and for losses in the interval [0.3, 1] automatically using
the training data only (inside the cross-validation). Finally, the classification
accuracy increased from 56% (classification of continous profiles after a multi-
resolutional preprocessing using ”GLAD”) to 65%.
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Figure 4.7: Threshold estimation for the discretisation. A) Number of discrimi-
nating regions (y-axis) for each analysed threshold (x-axis). Blue (full) dots denote
the number of discriminating regions for the analysed data set and red (empty)
squares the 95% quantile of the random experiments. B) P-values for the discrimi-
nation using each threshold. The best discriminating thresholds are 1.05 and 1.15.
Note that the p-values of all thresholds below 1 are above 0.05. This indicates that
the deletions of this data set are not as important as the amplifications.
4.2.7 Feature selection
I applied classifiers that can deal with high-dimensional data. Thus, a feature
selection is not necessary. However, the feature selection may enhance the
classification accuracy and the interpretability of the model.
Following the discretisation of genomic profiles, I selected genomic fragments
only that showed aberrations in at least 10% (or 20%) of all cases. That is,
each included aberration had to affect at least 4 patients (sample size 20...40).
An aberration affecting less than 4 cases is of little biological interest.
The features have to be selected independently from the class labels and with
respect to the training set (or an inner cross validation) only. Thereafter, the
same feature selection has to be applied to the (unseen) test data.
80 CHAPTER 4. MACHINE LEARNING OF GENOMIC PROFILES
4.3 Classifier design and evaluation
4.3.1 Classifier selection
Different classifiers were theoretically analysed in chapter 2. Finally, I used
support vector machines and the decision tree algorithm C5.0 (in an im-
plementation of Clementine) as classifiers according to their generalisation
performance and the availability of stable implementations.
Altogether, a support vector machine seems to be a good choice of a classi-
fication algorithm. A linear kernel of an SVM is appropriate for small data
sets. A polynomial kernel ”counts”the number of aberrations. Therefore, it is
interesting for discrete profiles. An RBF kernel is characterised by its univer-
sal approximator ability (section 2.4.5). I used an RBF kernel for continuous
profiles.
All kernels mentioned do not specifically reflect the biology (and spatial cor-
relation structure) of genomic profiles. An interesting alternative would have
been a special (string) kernel (e.g. [RSS05]). However, an appropriate pre-
processing of the data set and a standard kernel should be equivalent to a
specialised kernel function.
I suggest the use of decision trees for data sets with many missing values
(LOH data sets). Interestingly, the performance of the SVM and C5.0 was
comparable. This is caused by the low (observed) non-linearity of the given
data sets (low number of samples and high dimensionality). Boosting of the
decision trees did not improve the results.
4.3.2 Classifier adaptation
For an SVM, the choice of the kernel, the kernel parameters and the regulari-
sation constant C is crucial for a good generalisation performance for a given
data set. Subsequently, we search for a parameter vector p = (p1, .., pi)
t that
minimises the expected risk of an SVM classifier f :
pˆ = argmin
p
R(f(p)). (4.3.1)
An analytic solution is not possible. However, an upper bound of the para-
meter C for SVM-regression and the RBF-kernel can be estimated from the
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range of the target variable y [CM04]. In the case of outliers, C should be
selected as
C = max(|y + 3δy|, |y − 3δy|), (4.3.2)
where y is the mean and δy the standard deviation of the target variables y.
For SVM-classification, the estimation of the risk R(f) for each parameter
vector p can be based on methods described in sections 2.3 and 4.3.3. I used
a cross validation or a leave-one-out cross validation.
The different parameters p1,..,pi are not independent. Therefore, a separate
tuning of each parameter is not possible.
I employed an exhaustive search within a reasonable parameter space of the
support vector machine (as proposed by the authors of the implementation
libsvm [CL01]). For each parameter vector pj the performance of the classifier
is assessed (Fig. 4.8). The described grid search is time consuming but can
easily be parallelised.
Alternatives to an exhaustive parameter search would have been a gradient
descent algorithm using upper bounds of the empirical risk [CVBM02] or a
global optimisation algorithm based on Gaussian processes [FZ05].
For a reliable assessment of the classifier performance, the parameter tuning
has to be performed using the training data only (see section 4.3.4).
4.3.3 Classifier assessment
An assessment of a trained classifier can answer two different questions.
The first one relates to the separability of two classes and biologically reads
as ”Are different tumour types distinguishable?” The second question refers
to a global feature ranking and reads as ”Which aberrations distinguish one
tumour type from another?”
Methods to answer the first question are based on an estimation of the clas-
sification accuracy and will be discussed in the next part of this section. The
second question will be discussed in the third part of this section.
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Figure 4.8: Grid parameter search visualised by the SVM implementation libsvm
[CL01]. The x-axis depicts the parameter C and the y-axis the parameter γ (both
on a logarithmic scale). The classification accuracy is encoded by an equivalent
colour.
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Quantitative classifier assessment
Different methods for a numerical model assessment were considered in sec-
tion 2.3 from a theoretical point of view. But which method should be used
as a reliable estimate for the reader of a biological journal? Which method
reflects the separability of (two) tumour classes?
An empirical comparison of different model assessment techniques revealed
diverse results.
Kohavi compared 0.632 bootstrap, leave-one-out cross validation (LOO-CV)
and ten-fold cross validation (10-fold-CV), amongst others, using the decision
tree classifier C4.5 and data sets from the UCI repository [Koh95a]. The real-
world data sets from this repository are commonly used to compare machine
learning algorithms. He observed a higher variance of the LOO-CV and a
larger bias of the bootstrap. Finally, he recommended a stratified ten-fold
cross-validation.
A study of small-sample microarrays using the classifiers kNN (k-nearest
neighbour), lda (linear discriminant analysis) and the decision tree algorithm
CART revealed a high variance of both LOO-CV and 10-fold-CV [BND04].
LOO-CV and 10-fold-CV showed a comparable performance. In conclusion,
the authors recommended the computationally expensive bootstrap.
Molinaro et al compared different resampling methods on simulated gene ex-
pression data sets [MSP05]. The classification algorithms lda, dda (diagonal
linear discriminant analysis), kNN and CART were applied. The authors
concluded that LOO-CV ”generally performed quite well”, with the excep-
tion of unstable classifiers like CART. 10-fold-CV was quite comparable and
suggested for larger samples. The authors included a feature selection and in
this circumstance a cross validation (LOO-CV and 10-fold-CV) was better
than a bootstrap.
A comparison of model assessment methods using an SVM-classifier
[ABR+05] and data sets from the UCI repository revealed that a LOO-CV
outperforms a 10-fold-CV. However, a boostrap with 100 replicates was bet-
ter and a bootstrap with 10 replicates worse than a LOO-CV.
From a theoretical point of view, the LOO-CV sometimes overestimates the
prediction error. In a data set without a correlation between the feature
values and the class labels, a classifier would predict the class according to
the majority class of all cases in the learning set. A classifier in LOO-setting
would therefore always learn the wrong class (the class that is not left out)
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and predict an accuracy of 0% (assumption: balanced design, both class
labels have a share of 50%). Such a failure occured in the data set shown
in section 5.2.4, where the predicted accuracy was clearly below the 50%
expected of a random assignment in a two-class-problem.
To summarise, LOO-CV performs badly for unstable classifiers. LOO-CV
and 10-fold-CV have comparable results, although 10-fold-CV is characteri-
sed by a higher bias and LOO-CV by a higher variance. For small data sets
of approx. 10 samples, a 10-fold-CV and a LOO-CV would be the same.
Bootstrap has a low variance but sometimes a high bias.
Finally, I decided to use a LOO-CV estimator for most of the experiments
with a support vector machine. However, almost all (biological) conclusions
were backed up by another classifier (often the decision tree C5.0) in an
implementation of another software package (Clementine). The 10-fold-CV
for the decision tree was chosen according to the aforementioned problems of
the LOO-CV with unstable classifiers.
Qualitative classifier assessment
The algorithms discussed in this part of the section answer the question
”Which aberrations distinguish one tumour type from another?”This is based
on a global analysis of the classifier. In section 4.4.1, a case-based analysis
of a classifier is introduced. A case-based qualitative analysis answers the
question ”Why does a given tumour sample belong to tumour type B?”
For separable classes (classification accuracy 100%), I propose an algorithm
that identifies feature subsets such that each subset can be used to distin-
guish both tumour types (classes). Features with a low importance for the
classification are recursively discarded and the SVM retrained. An alterna-
tive approach would have been an analysis of all possible feature subsets.
However, this is an NP-complete problem.
Next, the question arises, whether the subsets found represent statistically
relevant features. I use permutation tests and calculate a p-value for each
discriminating subset found. The underlying test statistics is based on the
hyperplane distance.
The QP optimisation problem of the SVM can not always be solved effecti-
vely. However, difficult and time-consuming optimisation problems indicate
that the separation of both classes is difficult. Therefore, the learning pro-
cess of the SVM is stopped iff the time consumed for the QP-problem using
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Figure 4.9: Algorithm for the identification of discriminating feature subsets.
a feature subset takes much more time than the original problem with all
features.
Taken together, the algorithm reads as (Fig. 4.9):
1 Start with an SVM classifier trained with all features
2 Select the feature with the lowest importance for the classification
3 Discard this feature and retrain the SVM with all remaining features
4 Assess whether a separation of both classes with the remaining features
is still possible. If a separation is still possible, then go to step two.
Otherwise, a minimal discriminating subset of features was found.
5 Assess the importance of the minimal discriminating subset found. Save
an ”important” subset.
6 Discard all members of important subsets and redo the analysis (step
two).
Finally, and-or-trees can be used to represent the feature sets found (Fig.
4.9). An and-or-tree describes the composition of an expression in terms of
sub-expressions which are combined by ”and” or ”or” nodes. An and-node is
true iff all of its successors are true whereas an or-node is true if at least one
successor is true.
For non-separable data sets (classification accuracy below 100%), a feature
ranking was calculated according to [GWBV02]. Briefly, the most important
separating features were identified from the trained SVM classifier according
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Figure 4.10: Representation of discriminating feature subsets using an and-or-
tree.
to the absolute value of each component of the hyperplane direction vec-
tor. Guyon et al. also proposed a recursive feature elimination and used
the classification accuracy as criterion. However, the differences between the
classification accuraccies of feature subsets of varying sizes were not signifi-
cant. Therefore, the estimation of the optimal size of a discriminating feature
subset (given the analysed genomic profiles) was very difficult and finally not
used.
4.3.4 Reliability and reproducibility
Reliability and reproducibility are important issues in statistics and ma-
chine learning. For classification tasks, reliability and reproducibility are
not straightforward, due to the complexity of the algorithms and the size
of the data sets. Furthermore, the estimation of the classification accuracy
often depends on preprocessing steps.
It is important to base all parameter estimations on the training data set
only. For smaller data sets, where cross validation is the best choice, all
preprocessing steps have to be included in two nested cross validation loops.
The outer cross-validation loop estimates the classification error; whereas the
inner cross-validation loop selects the optimal parameter of the preprocessing
steps and the hyperparameter of the classifier [RHPM04], [Sal97].
Furthermore, a prerequisite for the interpretation of the classification error
is that the test data set is balanced. This means that the test data set
contains the same number of cases for each class. Otherwise, the specificity
and sensitivity of the classifier have to be taken into account.
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4.4 Case-based analysis of a classification re-
sult
Tailoring the appropriate therapy for a specific patient is an important chal-
lenge in cancer treatment. Genomic profiling in tumour research can improve
current diagnostic and prognostic classification schemes and may provide im-
portant information for choosing the appropriate therapy. A vast number of
classifiers based on genomic or gene expression profiles have been proposed
for different diagnostic tasks in the literature. However, there are only a few
classifiers in clinical routine use.
Therefore it seems worthwhile to think about strategies to adapt the know-
ledge from classifiers described in the literature for clinical decision support
systems. Such a clinical decision support system should include a core classi-
fication algorithm, a knowledge base, interfaces with the hospital information
system and an explanation component for the physician.
The classifier and the knowledge base are a trained model of a support vector
machine and therefore well established. Yet, little has been done to develop
a plausible explanation scheme for the user of a standard support vector
machine. But this explanation scheme is indispensable for most clinical ap-
plications. Here, I introduce an explanation scheme based on a few features
(genomic fragments) with a high explanatory value for a classified case. Fur-
thermore, I propose an explicit competence model to classify cases only which
are within the competence area of the classifier. The system estimates the
applicability of the support vector machine classifier for an unknown case to
be classified and provides a qualitative explanation for each classification.
4.4.1 Qualitative explanation of classification results
To develop an explanation component, it is worthwhile having a look at
human decision making.
Imagine the task of classifying fruits as apples. For each fruit, we search for
an explanation as to why this fruit was classified as “apple” or as “not-an-
apple”. Apparently, a human classifier can easily describe why an object was
recognised as an apple or not. Each classification outcome can be explained
in a few words, using a few features like the red, green or yellow colour or
the ellipsoidal shape. Yet, our explanation of apples depends on the apple we
classify. The classification of a little red apple is described due to its colour
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and the classification of a blotchy green apple due to its shape.
Another example relates to the important question of marrying. Charles
Darwin thought about it in 1887 [GTG99]. He wrote down many arguments
for and against a marriage.
MARRY
Children—(if it please God)—constant companion, (friend
in old age) who will feel interested in one, object to be
beloved and played with—better than a dog
anyhow—Home, and someone to take care of
house—Charms of music and female chitchat. These things
good for one’s health. Forced to visit and receive relations
but terrible loss of time. My God, it is intolerable to think
of spending one’s whole life, like a neuter bee, working,
working and nothing after all.—No, no won’t do.—Imagine
living all one’s day solitarily in smoky dirty London
House.—Only picture to yourself a nice soft wife on a sofa
with good fire, and books and music perhaps—compare this
vision with the dingy reality of Grt Marlboro’ St.
Not MARRY
No children, (no second life) no one to care for one in old
age....Freedom to go where one liked—Choice of Society and
little of it. Conversation of clever men at clubs.—Not forced
to visit relatives, and to bend in every trifle—to have the
expense and anxiety of children—perhaps quarrelling. Loss
of time—cannot read in the evenings—fatness and
idleness—anxiety and responsibility—less money for books
etc—if many children forced to gain one’s bread.—(But then
it is very bad for one’s health to work too much) Perhaps
my wife won’t like London; then the sentence is banishment
and degradation with indolent idle fool—
Charles Darwin, 1887 (cited after [GTG99])
How could he come up with a decision? Weighting all features in a
linear model? Would a person report the decision making process as
0.1×children+0.2×conversation with clever men at clubs? Charles Darwin
based his decision on one important argument only: “constant companion”
and wrote down beneath this argument “q.e.d. marry - marry - marry”.
Finally, he married his cousin one year later.
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In general, it has been shown that human decision making is often based on
heuristics [GTG99] and a few features only. Conscious decision making has a
limited capacity. Therefore, humans take a subset of available features into
account only when they decide [Dij04]. Even experts differ from non-experts
in their choice of the features used, not in their number [Sha92]. Interestingly,
the assumed natural limit for humans in decision processes is approximated
as seven features or dimensions [Mil56].
Explanation scheme
The basic idea of explaining a complex, numerical, high dimensional classi-
fier (based on many features) is to approximate the decision function for a
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Figure 4.11: Schematic explanation of a classifier for the separation of class
1 from class 2. A) Global, complex and non-linear explanation of the high-
dimensional classifier. The tangent on the case to be explained is shown. B)
Local explanation by a linear function within a neighbourhood of the case to be
explained. The linear function is the tangent of the non-linear classifier (A) on the
case to be explained. C) Local simplified explanation after local feature selection.
The resulting axis-parallel decision function correctly separates both classes within
the small neighbourhood and is based on one feature only.
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given case (e.g., a tumour sample) by an easily understandable linear and
low-dimensional classifier. This approximation is sufficient within a small
neighbourhood of the classified case only and based on a few characteristic
features (Fig. 4.11). Because humans usually do not explain their decisions
in the form of weighted linear models, the explanation is further reduced to
a few characteristic features of the linear model. This can be regarded as
a local feature selection in a small region around the classified case. The
selected features provide a reliable basis for a case-specific explanation of
the classification. Thus we can reformulate the question “How can the out-
come of a classifier be explained?” to “Which features are important for the
classification of a given case?”
Local approximation
Features with a high explanatory value for a classified case have a large im-
pact on the classification outcome. Variations of these features will likely
change the classification result. A case-based sensitivity analysis of all fea-
tures, i.e. the perturbation of one feature value at a time and monitoring
the classification variation, would provide a ranking of all features but would
demand high computational costs.
Here, I suggest only analysing the first partial derivatives of a modified SVM
decision function (4.4.2) to find features with a high explanatory value.
The original decision function of an SVM (4.4.1) is not differentiable:
f (x) = sign
(
M∑
i=1
yiαiK (si,x) + b
)
. (4.4.1)
si are the support vectors and αi, yi their weights and class labels respecti-
vely. M is the number of support vectors and K the kernel function. The
corresponding coefficients αi, and the bias constant b reflect the solution of
a quadratic programming problem and define the position of the separating
hyperplane.
Therefore the sign-function is replaced by the tanh-function in analogy to
neural networks [Bis95]:
f (x) = tanh
(
M∑
i=1
yiαiK (si,x) + b
)
. (4.4.2)
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For a linearly separable decision function (linear kernel)
K(si,x) =
N∑
j=1
(sijxj) (4.4.3)
the first partial derivatives of the decision function are:
∂f(x)
∂xj
=
∑M
i=1 yiαisij
cosh2
(∑M
i=1 yiαi
∑N
k=1 xksik + b
) . (4.4.4)
N is the dimensionality of the input space (number of features).
Similarly, the explanation of a non-linear classifier is based on the first partial
derivatives of the non-linear decision function. E.g., for the polynomial kernel
K(si,x) = (c+ γ
N∑
j=1
sijxj)
d (4.4.5)
the first partial derivatives are:
∂f(x)
∂xj
=
∑M
i=1 yiαiγd
(
c+ γ
∑N
k=1 xksik
)d−1
sij
cosh2
(∑M
i=1 yiαi
(
c+ γ
∑N
k=1 xksik
)d
+ b
) (4.4.6)
c, d and γ are constants.
Local feature ranking
All features j = 1..N are ranked for each classified case x = (x1, xj, ..., xN)
t
according to their explanatory value. The importance of a feature for the
classification of a given case is proportional to its explanatory value and
calculated from the first partial derivatives.
Since the denominator of the partial derivatives from the linear decision func-
tion (4.4.4) is equal for all features xj of a classified case, the explanatory
value of each feature is therefore independent from the classified case and
defined as:
e (xj) =
∣∣∣∣∣
M∑
i=1
yiαisij
∣∣∣∣∣ . (4.4.7)
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Figure 4.12: Schematic feature ranking of a linear classifier. The feature rankings
for the explanations of both classified cases are identical.
From a geometric point of view, the explanation can be obtained from the
normal vector of the decision hyperplane. Features with a high explanatory
value correspond to a high absolute value of the component of this feature in
the direction vector of the decision hyperplane (Fig. 4.12).
The denominators of the partial derivatives from non-linear decision func-
tions, e.g., for the polynomial kernel, are also equal for all features xj. The
explanatory value of each feature xj, j = 1..N depends on the classified case
x = (x1, xj, ..., xN )
t (Fig. 4.13) and is defined as:
e (xj) =
∣∣∣∣∣∣
M∑
i=1
yiαiγd
(
c+ γ
N∑
k=1
xksik
)d−1
sij
∣∣∣∣∣∣ . (4.4.8)
Local feature selection
The features with the highest ranking are selected for the explanation. The
number of features presented can be determined a priori by the user or
calculated by a recursive replacement strategy. This recursive replacement
strategy can also be used for the verification of the explanation.
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Figure 4.13: Local approximation and feature ranking of a non-linear decision
function. Different feature rankings for the explanations of two classified cases
were obtained.
The idea of the recursive replacement strategy is to falsify the classification
with a minimal number of alterations to the features of the classified case and
to use this alteration process as an explanation. The value of the highest-
ranked feature of a classified case from class 1 is replaced by the median
feature value of all cases from class 2. If the classification of the modified case
switches to class 2, an explanation for the classification of the case is found.
Otherwise, the values of the next highly-ranked features are additionally
replaced. The same strategy can be used for a classified case from class 2.
The resulting explanation comprises all highly-ranked features required for a
change in the classification result.
It is worthwhile to mention that the number of features found using the
recursive replacement strategy is case-specific, even for a linear classifier.
Adaption for missing and atypical values
To overcome some limitations of my explanation scheme, it was adapted for
data with missing values and atypical cases from regions with a low-density
distribution. If a feature value is missing for the case to be explained, it is
also omitted in the explanation. Furthermore, a feature is skipped if it is
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highly-ranked but of little explanatory value for the case to be explained. An
example may illustrate an atypical case for a linear classifier. The prostate
specific antigen (PSA) marker is normally increased in patients with prostate
cancer. So we may use the attribute PSA to distinguish the class “cancer”
from the class “control”. However, to explain why a patient with a low PSA
level has prostate cancer the attribute PSA is not appropriate.
Discussion
I proposed an explanation scheme for support vector machine classifiers ba-
sed on the selection of highly-ranked attributes in a case-based context of
a decision problem. More precisely, the features chosen for an explanation
were identified by local linear approximation of the complex decision func-
tion. This linear approximation served as a basis for local feature ranking
and local feature selection.
An application of this explanation scheme on the liposarcoma data set can
be found in section 5.2.3.
The new idea is to use a case-based analysis of the classifier. A global ranking
of all features (calculated from the decision hyperplane) would provide a
rough estimate of their case-based importance only. For an example data
set, shown in section 5.2.3, the global and case-based ranking differ even for
a linear kernel, e.g. due to missing values.
My explanation concept based on a few features is similar to the decision-
theoretic concept of lexicographic ordering. Lexicographic ordering refers
to a rank-order of all features. A comparison of attribute values is done
attribute-by-attribute until a feature discriminates between the two classes.
The strategy of lexicographic ordering assumes that a significant change of
the discriminating feature outweighs all less important features [GTG99]. In-
terestingly, this decision strategy is followed by oncologists in the assessment
of therapeutic options for primary breast cancer by focussing on the most
important attribute “chance of cure” [RSM87].
The application of artificial neural networks (ANNs) in diagnostic decision
making has been proven to show great potential (see [Lis02] for review).
Heckerling compared different feature ranking algorithms of ANNs, yet from a
global and not a case-based point of view. Although the explanation concept
presented here was developed for SVMs, it can be readily extended to other
classification schemes such as ANNs. The first order partial derivatives of an
ANN decision function could be evaluated by applying a sensitivity analysis
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or differentiable activation functions analogous to a paper by Hashem et al.
[Has92]. I focussed on SVMs because of their superior generalisation ability.
It might be argued that complex classifiers like SVMs and ANNs should be
replaced by intuitive classifiers like decision trees, being more adequate for
explanations. However, a decision tree is inappropriate to deal with non-
linearly combined features. Boosting simple and weak classifiers [FS96] also
lacks an intuitive explanation ability. Furthermore, the natural feature limit
for humans in decision processes should be taken into account. Thus, even
in the case of a more intuitive or linear classifier, the number of features for
an explanation should be restricted.
Another explanatory method for support vector machines was suggested by
Barakat and Diederich [BD05]. Briefly, all support vectors are extracted,
their class labels are discarded and predicted by the SVM. Then, a rule-
based machine learning technique (e.g., C5.0) is applied to this data set.
The goal here is to reveal rules upon which the predicions of the SVM are
based.
An alternative to machine learning approaches is a case-based reasoning sys-
tem (CBR) [Kol92]. A CBR infers the class label of a new case from similar
training cases. These cases represent the basis for an explanation of the clas-
sification. The support vectors of the trained support vector machine could
be used in a similar manner. The similarity measure (metrics) of a CBR also
provides information about the classifier. A sensitivity analysis of this simi-
larity measure for a new case could therefore reveal a case-based explanation,
analogous to the explanation scheme described here.
Another alternative would be a classic decision support system. As it re-
quires that the knowledge about different classes is explicitly given in a for-
mal language (e.g., first order logic, frames), it is not appropriate. A DSS
embodies a knowledge database, an inference engine and often an expla-
nation component. The formal representation of the knowledge remains a
great challenge, particularly in an emerging and dynamic field like molecular
genetics.
Future research should be directed towards the explanation of classifica-
tion problems with more than two classes. Furthermore, effective arguments
should be adapted for each user considering his/her values, preferences and
knowledge [CM01]. Consequently, I propose a usefulness factor for each fea-
ture to strengthen the relevance of an explanation for the user. The use-
fulness of an explanation could depend on the newness (information gain)
and relevance for clinical actions (actionability, [ST95]). If a physician is not
96 CHAPTER 4. MACHINE LEARNING OF GENOMIC PROFILES
familiar with an important attribute of the classification task then this attri-
bute should be included in an explanation. For ‘actionability’, a drug expert
system for physicians should base its explanations on alterable features (like
the drug dosage) instead of fixed features (like the age of a patient).
4.4.2 Competence estimation
A machine learning classifier will return an answer for each question posed.
However, some questions are beyond the knowledge of the classifier. Imagine
that a classifier for estimating the female breast cancer risk is applied to a
male patient. If the classifier has never been trained with male breast cancer
patients, the classifier is unlikely to be competent. The same problem occurs
if a classifier is trained with adult patients but is applied to children.
Therefore, I propose a competence check of the classifier as a part of a decision
support system. This competence check should also incorporate knowledge
about the applicability of a classifier in a given domain. A classifier may be
useful for women only, or not competent for classifying patients above the
age of 55. Therefore, important features of the patient have to be requested
from the user (or the hospital information system).
Generally speaking, a classifier seems to be competent if it has been trained
with cases similar to the case to be classified (Fig. 4.14). However, if the case
to be classified is atypical, then the competence of the classifier regarding this
case is very weak.
Mathematically, the case to be classified has to be drawn from the same
distribution as the training data. Therefore, the competence of a classifier
can easily be computed using a multi-dimensional (kernel) density estimation.
Another algorithmic solution would be the use of a one-class support vector
machine [SPST+01].
For neural networks, Bishop [Bis94] proposed a similar ”confidence measure”
σy(x) =
√
p(x), (4.4.9)
where p(x) is the unconditional density of the data.
Bishop suggested to use a threshold for the novelty based on an estimation of
σy(x) with respect to an independent test set. Furthermore, he recommended
to perform the novelty test prior to the preprocessing of the data.
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Figure 4.14: The competence of the classifier is estimated from the density
of training cases in its neighbourhood. The classifier is much more competent
regarding case A compared to case B.
Habermas et al [HZET07] proposed a case-based ”reliability framework” for
various classifiers. It is based on a local accuracy estimation
r(x) = 1− 1
Mv
Mv∑
i=1
L0/1(vi, f(vi)) for all {vi|D(vi,x) < dv,vi ∈ V}.
(4.4.10)
The ”validation pool”V is drawn from the same distribution as the training
data. For a case to be classified, similar cases {vi|D(vi,x) < dv,vi ∈ V}
from the validation pool are selected which are within a maximal distance
dv from the query case x. Based on this case-specific validation set, a local
accuracy is determined. If the local neighbourhood is empty, that means all
cases of the validation pool V have a distance from the query case x greater
than dv, the case is referred to as a ”no-neighbour case”. Crucial is here the
choice of the distance function D and the distance threshold dv.
4.4.3 Classification certainty
The classification certainty provides the user of a decision support system
with a number determining the reliability of a classification result. Classified
cases next to the decision hyperplane are much more unreliable compared to
cases further from the decision hyperplane.
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Figure 4.15: The classification certainty is calculated from the distance to the
hyperplane. Accordingly, the classification of case A is much more unreliable than
the classification of case B.
Additionally, I used this classification certainty to visualise the assignment
of tumour probes and the corresponding feature patterns (e.g. Fig. 5.4 and
5.16).
If the distances to the hyperplane were normally distributed, then a posterior
probability P (y = class 1|x) could directly be estimated from the distances
to the hyperplane using Bayes’ rule.
Platt suggested to estimate the posterior by mapping the distances to a
sigmoid function [Pla99b]:
P (y = class 1|x) ≈ 1
1 + exp(A
(∑M
i=1 yiαiK (si,x) + b
)
+B)
(4.4.11)
The parameter A and B of this sigmoid function are calculated from the
training data by solving a maximum likelihood function. I used an imple-
mentation by Lin et al [LW93].
Interestingly, the local accuracy estimation [HZET07]
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r(x) = 1− 1
Mv
Mv∑
i=1
L0/1(vi, f(vi)) for all {vi|D(vi,x) < dv,vi ∈ V}.
(4.4.12)
could be used for the estimation of the classification certainty as well (see
section 4.4.2 for details).
For a multi-class classification problem, the classification probabilities can
be estimated as proposed by Huang et al [HWL06] based on error correcting
output codes [DB95].
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—————————————————————————–
Chapter 5
Applications
In this thesis, I developed a workflow for classifying genomic profiles and
applied it to various data sets. Please note that the workflow presented in
chapter 4 evolved over time. Subsequently, some data sets were analysed
with preliminary methods.
The main parts of this chapter have previously been published. My main
contribution to the following projects concerned the preprocessing of the data
sets, the visualisation, classification and a basic statistical analysis. However,
I will focus here on the classification tasks and unsupervised machine learning
methods (like clustering, principal component analysis and self-organising
maps).
Table 5.1 provides an overview about the dimensionality (number of features),
size (number of cases), type of genomic profile (matrix-CGH, LOH or classical
CGH) and the chosen classification method of all data sets.
Three of the following studies analyse single disseminated tumour cells (pro-
jects 1, 5 and 6). These cells can be detected in bone marrow of can-
cer patients by staining with the anti-cytokeratin antibody. Approx. 1-2
cytokeratin-positive cells can be found in 1 million bone marrow cells of
cancer patients without known metastases. Furthermore, the presence of
cytokeratin-positive cells has a prognostic impact on the survival of these
patients [BPM+00, Kle03].
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Data set Dimen-
sionality
Size Profile-
type
Classification
method
Early metastasis
(project 1) 60 32-42 CGH SVM
Ductal and lobular
breast cancer (project 2) 6000 40
matrix-
CGH
SVM
Liposarcoma
(projects 3 and 4) 228 16
matrix-
CGH
SVM
Early breast cancer
(project 5) 2464 21
matrix-
CGH
SVM
LOH analysis of single cells
(project 6) 48 86 LOH Decision tree
Table 5.1: Short description of the classification tasks.
5.1 Classical CGH
5.1.1 Early metastasis in HER-2 transgenic mice
The description of the first analysis is based on [HGS+08] and unpublished
results. The CGH-analysis of single cells and microdissected tumour samples
was done by Yves Hu¨semann and Jochen Geigl under the supervision of
Christoph Klein, University of Munich. My main contributions were a classi-
fication analysis, the calculation of the tumour growth and the analysis of the
similarity/dissimilarity between primary tumours and distant tumour cells.
Introduction
The tumour size of most human cancers, including breast cancer, correlates
positively with the development of metastases. The prevailing doctrine is
that tumour cells capable of dissemination and metastasis generally evolve
late during tumour growth. However, metastases also develop in patients
with small cancers or even in the absence of detectable primary tumours
(so-called ”cancer of unknown primary”).
To determine when carcinoma cells disseminate and how metastases arise,
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we followed cancer progression from earliest detectable epithelial alterations
to metastasis in a mouse-model (HER-2 transgenic mice). Such a mouse mi-
mics progression and gene expression profiles of human breast cancer. Female
mice, which are hemizygous for the constitutively activated rat HER-2 gene,
start to express the oncogene at the onset of puberty (weeks 3-4 of age) when
the mice become responsive to steroid sex hormones. At week 7, morpholo-
gical changes in the breast, comparable to an atypical hyperplasia, become
regularly visible. Between weeks 15-18, the mice develop in situ carcinomas
and between week 22-30 all breast glands are transformed to invasive cancers.
The mice are euthanised between weeks 27 and 33 when primary tumours
exceed 1.5 cm in diameter and at about the same time metastasis to the lung
becomes macroscopically detectable.
The HER-2 negative siblings of these mice (wild type mice) remained tumour
free.
Methods
Classification analysis of clonal relationship
I applied the support vector machine (SVM) implementation libsvm (www.
csie.ntu.edu.tw/~cjlin/libsvm) as the classifier in a leave-one-out cross-
validation (LOO CV) design with a grid parameter search within the LOO
CV. A weighted SVM for unbalanced data and the RBF kernel were used.
The confidence intervals for the classification accuracy values were calcula-
ted as published [Mit97]. My conclusions were confirmed using a balanced
LOO CV design and the classifier C5.0 in clementine (http://www.spss.
com/clementine). The ranking of the chromosomal regions (regarding their
importance for the classification) was calculated from the trained classifier
according to the absolute value of each component of the hyperplane direc-
tion vector [GWBV02]. Classification probabilities were calculated according
to Platt [Pla99b] in an implementation of libsvm [CL01].
Statistical and bioinformatical analysis of clonal relationship
The similarity between aberrations of two encoded (amplification +1, dele-
tion -1) samples was obtained using the Manhattan distance. Briefly, the
similarity is the sum of all differences in aberrations at which a difference
between a deletion and amplification counts two and the difference between
a balanced area and an amplification or deletion counts one. The p-value
was calculated using an exact, paired, one-sided Wilcoxon signed rank test.
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Clustering
I applied the clustering of proteases using Euclidean distances, complete lin-
kage for proteases and average linkage for cases. The stability of the cluster
was assessed using BRB ArrayTools developed by Dr. Richard Simon and
Amy Peng [MRF+02].
Calculation of tumour progression over time
I calculated the tumour areas and tumour volumes from 407 mammary glands
of 41 mice assuming the shape of an ellipse/circle and ellipsoid/sphere respec-
tively for each tumour. The tumour size/area of a mammary gland without
a tumour was set to zero. The curve was fitted using Friedman’s scatterplot
smoother [Fri84]. HER-2 positive cells from 31 samples (28 mice) and CK
positive cells from 33 samples (31 mice) were calculated as the sum of single
disseminated cells and the number of aggregates. Measurements from simi-
lar time points (+/- 1 week) were consolidated. An offset of +/-0.3 weeks
was used to draw HER-2 and CK positive cells in one plot. The number
of positive CK and HER-2 cells from non-transgenic mice were measured in
25 mice (CK) and 24 mice (HER-2) at five time points (weeks 4, 9, 18, 22,
29) and connected by a dotted line. The area of lung metastases was mea-
sured using the PALM Robo V1.2.3 software and calculated as the sum of
all metastases found. Values were averaged over two tissue sections. Four
operated mice and 14 non-operated mice were measured. The curves were
fitted using Friedman’s scatterplot smoother. All analyses were performed
using the statistical language R (www.r-project.org).
Microarray analysis
Contamination by stromal cells was excluded by laser microdissection. After
global mRNA amplification, PCR amplified cDNA fragments were digoxi-
genin labelled and non-radioactive hybridised to nylon filters. The cDNA
array comprised 41 molecules belonging mostly to the families of matrix-
metalloproteases (MMPs), cathepsins and their inhibitors. Significance ana-
lysis of microarrays (SAM) was performed as published [TTC01].
Detection of micrometastases and single disseminated cells
Micrometastases to the lung were detected using an antibody against the
HER-2 transgene. Normal lung tissue did not express the antigen. For de-
tection of tumour cells disseminated to the bone marrow, antibodies against
the HER-2 transgene and an antibody against epithelial cytokeratin (CK)
were used. Both antibodies showed negligible background positivity in the
bone marrow of non-transgenic mice with the cytokeratin antibody being
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more specific.
CGH analysis
Laser microdissection of several areas of the primary tumour was performed.
Metastases from the lungs were also microdissected whereas the disseminated
tumour cells isolated from the bone marrow were analysed as individual cells.
The CGH profiles obtained were translated into a table, after dividing each
chromosome into three parts (A-C).
Results and discussion
Single disseminated cancer cells could already be detected in bone marrow
and lung tissue in week 9 - a time point at which tissue morphology is com-
parable to atypical hyperplasia. The cancerous origin of these single disse-
minated cancer cells was confirmed by analysing their (aberrated) genomic
profiles using CGH. The kinetics of tumour cell dissemination to bone marrow
(BM) was found to be constant until week 27 despite an enormous increase
of tumour cells at the primary sites. The same phenomenon was observed for
lung micrometastases (Fig. 5.2 and 5.3). Initiation of metastasis apparently
occurred very early in tumourigenesis and became less likely as the tumours
grew.
We compared the genetic aberrations of the primary tumours to those of
the disseminated cells and lung metastases (Fig. 5.1). While the classical
progression model would predict that tumour cells accumulate chromosomal
abnormalities at the primary site and display them also at the distant site,
early dissemination and parallel outgrowth would result in vast divergence.
Thus, the genomic comparison determines whether the disseminated cells are
similar to the predominant clone within a primary tumour. We analysed all
primary tumours of two animals in week 27 (PT; n=20), their lung metastases
(LM; n=8) and disseminated cancer cells isolated from the bone marrow
(BMDT; n=10) by CGH.
We asked whether or not the observed patterns of CGH abnormalities in LM
and BMDT were more closely related to the primary tumour than the 10
different primary tumours of a mouse to each other. On average, the genetic
distance between primary tumours and BMDT or LMs was similar to the
distance between the polyclonal primary tumours (for mouse 91 between 10-
13 divergent aberrations and for mouse 102 between 6-8). Therefore, we could
not find support for the hypothesis that the BMDTs or LMs are derived from
the predominant clone of the primary tumour.
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To check, whether genomic profiles of tumour cells from different organs
show variations, we designed a classifier trained to distinguish between pri-
mary tumours (PTs; n=26), LMs (n=16) and BMDTs (n=16) from various
animals. PTs and BMDTs or LMs could be separated with identical, high
accuracy (80%; the 95% confidence interval being 60-90%; Fig. 5.4 and 5.5).
By ranking the chromosomal regions that were most informative for the clas-
sification result, we could determine a panel of chromosomal abnormalities
characteristic of tumour cells growing at different anatomical sites. Primary
tumours and lung metastases were differentiated by a loss of chromosome
XB, 15C and 4C in the primary tumour, while chromosome 15C is mostly
gained in lung metastasis. BMDTs less frequently displayed alterations on
chromosome 4, X and 17 than primary tumours. LMs and BMDTs could
hardly be differentiated (classification accuracy approx. 50%; Fig. 5.6).
Furthermore, we compared the expression of invasion-associated proteases
in atypical hyperplasia at week 9 and large carcinomas at week 27. We
found a significantly higher expression of cathepsins (Ctsz, Ctsb, Ctsf, Ctsl,
Cstb,Ctsd, Ctsh), members of the MMP system (Mmp2, Mmp14, Mmp11,
Timp3) and two caspases (Casp2 and Casp9) at the early stage of tumour
development (false discovery rate q = 4.7% for week 9 compared to week
≥27). Of these, Ctsz (p-Value 0.0046), Ctsd (0.0046), Mmp2 (0.009), Ctsh
(0.0132), Ctsb (0.0215) were highly significant applying a one-sided Wilcoxon
test (corrected after Hochberg). The two groups (week 9 vs. ≥ 27) could be
visually separated by cluster analysis of the gene expression patterns (cluster
robustness index = 0.901; Fig. 5.7) with the exception of few outliers. A
principal component analysis (PCA) also showed that the two groups (week
9 vs. ≥ 27) could be separated on the basis of a gene expression analysis
limited to members of the proteolytic system (Fig. 5.8).
Together, we found metastatic cells in lung and bone marrow at a time when
mammary glands displayed histologically atypical hyperplasia only and no in-
vasive carcinoma. At that stage, electron microscopy revealed microinvasion
of the basement of stem-like cells. Disseminated cells in bone marrow expres-
sed distinct stem/progenitor cell markers and eighty of these cells - injected
into wild-type siblings sufficed to induce massive carcinosis of the recipients’
bone marrow. Since neither the origin nor the tumourigenicity of the early
disseminated cancer cells can be easily dismissed, the concept of metastasis
as being a late event in oncogenesis may be in need of reconsideration.
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Figure 5.1: Genomic relationship between primary tumours (T) and dissemi-
nated tumour cells from bone marrow (B) and lung metastases (L). (A and B)
For each primary tumour of mouse 91 (A) and 102 (B) the genetic distance to
the closest related T, L and B is shown. (C-F) The genomic profile of all B and
L displaying a genetic distance of less than 7 from a primary tumour are shown
in detail, together with the respective primary tumours (the selected samples are
indicated by ellipsoids in panel A and B). The genetic distance was calculated as
the Manhattan distance of the CGH profile values which were encoded as -1 for a
deleted region, 0 as balanced region and +1 for an amplified region.
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Figure 5.2: Progression of local and systemic disease over time. A/B) Increase
of tumour volume and tumour area (triangles indicate mean values, whiskers 95%
confidence interval with solid line between triangle indicating best fitted curve).
C) Number of cytokeratin+ (red dots) and HER-2+ (blue dots) cells in bone
marrow (whiskers indicate 95% confidence interval, dashed red or blue line depicts
results from non-transgenic control mice for cytokeratin or HER-2, respectively).
D) Average area of lung metastases (note logarithmic scale) in an individual mouse
(blue indicates average size of non-operated mice at various time points, red the
average size of operated animals at 10-15 weeks after surgery, whiskers indicate
95% confidence interval).
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Figure 5.3: Primary tumour growth and tumour cell dissemination to lung and
bone marrow. Cancer cell dissemination to lung and bone marrow (BM) in the
course of time. The number of dissemination events (single cells plus clusters)
was divided by the total tumour volume in mm3. Cancer cells were identified by
anti-HER-2 staining in lung sections, and by anti-HER-2 and anti-CK staining in
bone marrow.
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Figure 5.4: Results from the classifier trained to distinguish between primary
tumours (T) and lung metastases (L). The samples (rows) were sorted according
to probability to be classified as ”lung metastasis”. Chromosomal regions (columns)
are ranked according to the information they provide to the classification result
(green, chromosomal gain; red, chromosomal loss) and the best 20 chromosomal
regions are shown only.
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Figure 5.5: Results from the classifier trained to distinguish between primary
tumours (T) and bone marrow derived tumour cells (B). The samples (rows) were
sorted according to probability to be classified as ”bone marrow derived cell”. Chro-
mosomal regions (columns) are ranked according to the information they provide
to the classification result (green, chromosomal gain; red, chromosomal loss) and
the best 20 chromosomal regions are shown only.
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Figure 5.6: Results from the classifier trained to distinguish between bone mar-
row derived tumour cells (B) and lung metastases (L). The samples (rows) were
sorted according to probability to be classified as ”lung metastasis”. Chromoso-
mal regions (columns) are ranked according to the information they provide to
the classification result (green, chromosomal gain; red, chromosomal loss) and the
best 20 chromosomal regions are shown only.
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Figure 5.7: Activation of the proteolytic system during atypical hyperplasia.
Cluster analysis of gene expression data. Samples from young transgenic mice
(rows) could be separated on the basis of expression of molecules of the proteo-
lytic system (columns). Sample identifiers consist of age in weeks, the number of
the mouse from which the sample was taken and the sample number; individual
samples from one animal were isolated from different mammary glands.
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Figure 5.8: Principal component analysis of gene expression data. Samples from
young animals (week 9, here shown as ”9”) and old animals (week 27,28, 29, shown
as ”27’, ”28”, ”29”) could be separated on the basis of expression of molecules of
the proteolytic system. Note that only two samples from week 27 and 28 are found
between samples from week 9.
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5.2 Matrix-CGH
5.2.1 Genomic profiling of ductal and lobular breast
cancer
This matrix-CGH study was published in [SRS+06]. The profiling was done
by Daniel Stange under the supervision of Bernhard Radlwimmer at the la-
boratory of Prof. Peter Lichter, DKFZ Heidelberg. I analysed the difference
between ductal and lobular profiles as well as correlations with other histo-
pathological variables by means of machine learning and classical statistics.
Introduction
Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) re-
present the major histological subtypes of invasive breast cancer. They differ
with regard to presentation, metastatic spread and epidemiological features.
However, the molecular basis for differences in phenotype and clinical be-
haviour between ILC and ICD are not yet understood. To elucidate the
genetic basis of these differences, we analysed copy number imbalances that
differentiate the histological subtypes.
Methods
Genomic profiling
High-resolution genomic profiling of 40 invasive breast cancers using matrix-
comparative genomic hybridisation with an average resolution of 0.5 Mega
base pairs was conducted on bacterial artificial chromosome microarrays.
Preprocessing
Fluorescence intensities of all spots were filtered (intensity/local background
>3; mean/median intensity<1.3; standard deviation of genomic fragment log
ratios <0.25) and normalised block-wise according to Loess [BIAS03]. Chro-
mosomal breakpoints delimiting regions were then detected by GLAD (Gain
and Loss Analysis of DNA), a method developed by Hupe´ et al. [HST+04]
based on the Adaptive Weight Smoothing (AWS) procedure. The parameters
of GLAD were adjusted through several hybridisations of normal-proband-
DNA against pool-DNA from five normal probands as negative and cell line
experiments with well known genomic aberrations as positive controls. The
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thresholds differentiating balanced and altered regions were 1.12 for gains
and 0.88 for losses and were set in such a way that no false positive region
was found in the control hybridisations.
Significance Analysis of Microarrays (SAM)
Significance Analysis of Microarrays (SAM) was performed for discretised
copy number ratios using an implementation of SAM for categorical variables
(kindly provided by Holger Schwender) with a false discovery rate of < 5%.
This procedure differs from the original SAM in the use of Chi-squared ins-
tead of t-test statistics [Sch04]. All copy number values were discretised and
encoded as -1 for a deletion (ratio <0.88), 0 for a balanced genomic frag-
ment and +1 for a gain (ratio >1.12). SAM was performed on all genomic
fragments which showed aberrations in at least 20% of all cases. This pre-
selection of genomic fragments was done independently from the class label
and a simulation showed that the number of false positive genomic fragments
is still controlled.
Machine learning analysis
The support vector machine (SVM) implementation libsvm was used as the
classifier in a leave-one-out cross-validation (LOO CV) design with a grid
parameter search within the LOO CV. The SVM (RBF-kernel) was used on
discretised copy number ratios. The threshold differentiating balanced from
aberrated genomic fragments was automatically chosen for each run inside the
cross-validation (by maximally selected statistics) to avoid overfitting. Inside
the cross-validation genomic fragments were used that showed aberrations for
at least 10% of all cases. The most important separating chromosomal regions
were calculated from the trained SVM classifier according to the absolute
value of each component of the hyperplane direction vector [GWBV02].
Unsupervised hierarchical clustering and classical statistics
The clustering of all ILC and IDC was done for the Manhattan distance and
Ward’s linkage with discretised copy-number ratios. Associations of histo-
pathological parameters and number of aberrations with the clustering were
tested by Fisher’s exact test and Kruskal-Wallis test. An association of each
clustering subgroup with histopathological parameters and number of aber-
rations was tested by using an exact Wilcoxon signed rank test (corrected by
Hochberg). All analyses were done in the open source statistical environment
R, version 1.91 (http://www.r-project.org).
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Results and discussion
To identify regions that were important for the discrimination of IDC and
ILC by independent and rigorous biostatistical methods, I did both an SVM
and a SAM analysis (Fig. 5.9).
The 128 top-ranked fragments selected by SVM map to chromosomal regions
on 1q and 16p, identifying them as the most significant discriminators of
IDC and ILC. An optimal classification accuracy of 65% was achieved using
a classifier consisting of 733 genomic fragments.
An implementation of SAM, specifically adapted to the analysis of DNA copy
number data, was used to identify the fragments that were imbalanced with
significantly different frequencies in the histological subtypes. 116 genomic
fragments were identified that cluster in two regions, one on chromosome
1q24.2-q31.3 and the other on 16p11.2.
These regions were further narrowed down to subregions 1q24.2-25.1, 1q25.3-
q31.3, and 16p11.2. Located within the candidate gains on 1q are two genes,
FMO2 and PTGS2, known to be overexpressed in ILC relative to invasive
ductal carcinoma. Assessment of four candidate genes on 16p11.2 by real-
time quantitative PCR revealed significant overexpression of FUS and IT-
GAX in ILC with 16p copy number gain.
Unsupervised hierarchical cluster analysis identified three molecular sub-
groups that are characterised by different aberration patterns, in particu-
lar concerning gain of MYC (8q24) and the identified candidate regions on
1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. These genetic subgroups differed
with regard to histology, tumour grading, frequency of alterations and oes-
trogen receptor expression.
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Figure 5.9: Discriminating regions on 1q and 16p identified by different analysis
methods. The different regions identified by SVM and SAM were compared with
matrix-CGH profiles and plotted against the ideograms (schematic chromosomal
map) of chromosomes 1 and 16. The localisation of candidate genes is indicated.
Figure taken from [SRS+06].
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5.2.2 Genomic profiling of dedifferentiated and pleo-
morphic liposarcoma
This section is based on [FSW+02]. The genomic profiling was performed by
Bjo¨rn Fritz at the laboratory of Peter Lichter. My task was the statistical
and bioinformatorical analysis of the genomic profiles.
Introduction
Liposarcomas represent the most common soft tissue tumours in adults and
account for 20% of all mesenchymal malignancies. The tumours are charac-
terised by a high morphological diversity. Five morphological liposarcoma
subtypes can be distinguished:
• pleomorphic liposarcoma (PL)
• dedifferentiated liposarcoma (DL)
• myxoid liposarcoma
• round cell liposarcomas and
• well differentiated liposarcomas.
Sixteen dedifferentiated and pleomorphic liposarcomas were analysed by
comparative genomic hybridisation (CGH) to genomic microarrays (matrix-
CGH). The low number of samples resulted from the fact that liposarcomas
are rare tumours and the developmental status of the matrix-CGH method
at the time of the hybridisations (2000).
Methods
Genomic profiling
The genomic profiles of this study were based on 228 genomic fragments
arrayed on a matrix CGH-chip. The matrix-CGH chip was built from a
genome-wide array and additional genomic fragments from the region of
interest. 116 genomic fragments were approximately equidistantly arrayed
whereas 112 additional genomic regions were located in a region of interest
(chromosome 12q).
Cluster analysis
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I applied the clustering algorithm Two-Step in an implementation of Cle-
mentine (version 4) with a predefined number of four clusters. The principal
component analysis was done using J-Express 2.01d.
Machine learning
Predictive genes were revealed using an implementation of the decision tree
algorithm C5.0 in Clementine and the support vector machine SVM light.
A support vector machine was used for tumour type assignment of the two
initially unclassified samples PL39 and DL48. The class assignment proba-
bilities of these unclassified cases were calculated from the distance to the
hyperplane using Bayes’s rule.
Results and discussion
Matrix-CGH revealed copy number gains of numerous oncogenes, i.e.,
CCND1, MDM2, GLI, CDK4, MYB, ESR1 and AIB1, several of which cor-
relate to a high level of transcripts from the respective gene. Self-organising
maps ([Koh95b]) and a principal component analysis uncovered a clear sepa-
ration of both tumour subtypes (Fig. 5.11 and Fig. 5.12).
A classification analysis using the decision tree algorithm C5.0 and an SVM
also showed a separation of both classes (leave-one-out accuracy 100%). Mo-
reover, the prediction of the tumour type of two initially unclassified samples
revealed the experimentally validated class assignments and a low error pro-
bability of ≤ 5%.
Copy number changes of oncogenes and tumour suppressor genes in the eight
DL and eight PL analysed are indicated in Fig. 5.10. High-level amplifica-
tions (intensity ratio 2) were detected for CCND1, CCND2, MYB, MDM2,
GLI and CDK4. The highest ratio values were observed for MDM2, GLI and
CDK4 localised on chromosomal subregion 12q13–q15 and were present in
all DL tumours.
The best discriminators between pleomorphic and dedifferentiated were de-
rived from DNA fragments mapping on chromosome 12q including CDK4,
MDM2, and GLI and RP11-1143G9. Amplification of these clones together
with the characteristic amplicon structure found in DL not only allows a
clear discrimination from PL but strongly argues for different pathogenic
mechanisms leading to these liposarcoma subtypes.
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Figure 5.10: Liposarcoma dataset. Each column denotes a case and each row
a genomic fragment. Dark green, high-level amplification (log2 1); light green,
low-level amplification (log2 0.32); red, deletion (log2 0.41); black, balanced (log2
0); white, unknown.
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Figure 5.11: Self-organising map of the liposarcoma dataset. U-matrix represen-
tation of the tumour samples in a self-organizing map with four neurons. Samples
from the dedifferentiated liposarcoma (DL) were assigned to neurons 1 and 2 and
the samples from the pleomorphic liposarcoma (PL) to neurons 3 and 4. The co-
lours (or grey values) visualise the distance between the neurons in input space:
magenta (dark gray) corresponds to the smallest and yellow (light gray) to the
largest distance.
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Figure 5.12: Unsupervised analysis of eight PL and eight DL cases using matrix-
CGH data and the principal component algorithm (see text). DL and PL tumours
are clearly separated in the first main component as indicated by their different
plane position.
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5.2.3 Understanding the classication of liposarcoma
tumours with a support vector machine
Introduction
Here, I present an application of the case-based analysis of classification
results (section 4.4.1) on the liposarcoma data set introduced before. This
data set was exemplarily chosen due to the separability of both classes (100%
classification accuracy).
The underlying data set was kindly provided by Bjo¨rn Fritz. An earlier
version of this section was part of a publication at the German Conference
on Bioinformatics 2003 [SMF+03]. Parts of the calculations were performed
by Jasmin Mu¨ller in her diploma thesis which I supervised.
Methods
204 of the 226 DNA fragments with validated measurements for at least 13
tumour probes were included. svm-light was used as an implementation
of a support vector machine [Joa99]. The SVM was trained on 15 cases
while the remaining case was classified and analysed for explanatory features
(genomic fragments). Due to the limited amount of tumour probes, I applied
an SVM with a linear kernel.
The case-based analysis framework is explained in section 4.4.1.
Results and discussion
The case-based feature ranking revealed the importance of genomic frag-
ments on chromosome 12q for the discrimination between pleomorphic and
dedifferentiated liposarcoma (Table 5.2). Using the replacement strategy, the
number of genomic fragments (out of 204) needed to explain the classification
outcome for each tumour probe was estimated at between one and five .
As an example, case DL48 (dedifferentiated liposarcoma) is classified as de-
differentiated due to the DNA fragments 12q B438N16 and 12q B1143G9
(Fig. 5.13). The normalised copy number ratio for 12q B438N16 is 3.04
for case DL48, 0.11 for the average of all pleomorphic liposarcomas (PL) and
2.87 for the average of the remaining dedifferentiated liposarcomas (DL). The
normalised copy number ratio for 12q B1143G9 is 2.55 for case DL48, 0.19
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for the average of all pleomorphic liposarcomas (PL) and 2.62 for the average
of the remaining dedifferentiated liposarcomas (DL).
A modification of these two feature values for the dedifferentiated tumour
probe DL 48 to the mean values of pleomorphic tumour probes lead to the
prediction pleomorphic. In detail, a support vector machine predicts the
label dedifferentiated based on the feature vector of case DL48. Next, the
feature vector of case DL 48 is modified such that the feature 12q B438N16
becomes 0.11 (average of all pleomorphic liposarcomas) and the feature 12q
B1143G9 becomes 0.19 (average of all pleomorphic liposarcomas). All other
202 features remain unchanged. Finally, the support vector machine predicts
the label pleomorphic based on the changed feature vector of case DL48.
That means the modification of two out of 204 feature values to average
values of the other class is sufficient to change the classification outcome.
Likewise, a change of selected feature values for a pleomorphic tumour probe
shifted the outcome to dedifferentiated.
avg PL
(0.11)
avg DL 
(2.87)
case
avg PL 
(0.19)
avg DL
(2.62)
case
(3.04)
(2.55)
Copy number ratio
12 q B438N16
Copy number ratio
12 q B1143G9
Case DL48
classified as DL
2
0
1
2
0
1
3
Figure 5.13: Explaining the classification of liposarcomas. Two chromosomal
regions were identified for the classification of case DL48: 12q B438N16 and 12q
B1143G9. The value of both features from case DL48 is characteristic for the
average (avg) value of dedifferentiated liposarcomas (DL).
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The results clearly indicate the importance of aberrations on chromosome 12q
for the distinction between pleomorphic and dedifferentiated liposarcoma.
This is consistent with former results [FSW+02].
Case Important DNA fragments for the
explanation of this case
PL6 12q B438N16; 12q B1143G9
PL11 12q B438N16; 12q13-q15 CDK4;
12q13 MDM2; 12q B1007B5;
12q Control G1749
PL15 12q B438N16; 12q B1143G9
PL25 12q B438N16; 12q B1143G9
PL32 12q B438N16; 12q B1143G9
PL33 12q B438N16; 12q B1143G9
PL40 12q B438N16; 12q B1143G9;
12q13-q15 CDK4
PL39 12q B438N16; 12q13-q15 CDK4
DL10 12q B438N16; 12q B1143G9;
12q13-q15 CDK4
DL28 12q B438N16; 12q B1143G9
DL29 12q B438N16; 12q B1143G9;
12q13-q15 CDK4; 12q13 MDM2
DL41 12q B1143G9
DL42 12q B438N16; 12q B1143G9
DL45 12q B438N16; 12q13 MDM2
DL47 12q B438N16; 12q B1143G9
DL48 12q B438N16; 12q B1143G9
Table 5.2: Features explaining the classification of a tumour probe. The case
identifiers refer to [FSW+02].
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5.2.4 Genomic profiling of early breast cancer
This section covers an application of matrix-CGH drafted in [WSS+08]. A
customised chip from Donna Albertson’s laboratory was used and the hybri-
disations were performed by Rick Segraves. The preparation of the tumour
samples and the biological assessment was done by Ute Wo¨lfle. I was res-
ponsible for the annotation of the genomic fragments and the statistical and
bioinformatorical analysis.
Introduction
Genomic profiles of 21 breast cancer patients were analysed using matrix-
CGH to identify genomic aberrations associated with bone marrow (BM)
micrometastasis or lymph node (LN) metastasis. A cDNA analysis of a sub
set of these tumours previously revealed a specific gene expression signature
associated with bone marrow micrometastasis [WCS+03].
Tumours were derived from 16 patients without lymph node (LN) metastases
(pN0; LN-) and five patients with nodal metastases (pN1; LN+). Eight of
the 16 pN0-patients exhibited tumour cells in their bone marrow (BM+), as
revealed by immunostaining with an anti-cytokeratin antibody.
Methods
Hybridisation
The chip, used in this matrix-CGH analysis, contained 2464 genomic frag-
ments, providing an average resolution of 1.4 Mb over the genome. All ge-
nomic fragments were spotted in triplicate (3 measurements per genomic
region). Female tumour DNA was hybridised with male reference DNA so
that on the x-chromosome (numbered as chromosome 23) a DNA gain and on
the y-chromosome (numbered as chromosome 24) a DNA loss could clearly
be detected and demonstrated the reliability of the array CGH results. For
further analyses the values of the y-chromosome were omitted.
Data analysis
I updated the positions of the genomic fragments, originally assigned in Au-
gust 2001, in April 2005 (UCSC database, www.genome.ucsc.edu). Ratios
of genomic profiles for which only one of the triplicate remained after the
quality check were excluded from further analysis.
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Smoothing
Smoothing and chromosomal breakpoint identification was conducted using
GLAD (Gain and Loss Analysis of DNA), a method developed by Hupe´ et al.
[HST+04] based on the Adaptive Weight Smoothing (AWS) procedure. The
threshold of the log2 transformed fluorescence ratios differentiating balanced
from altered regions were 0.3 for DNA gains and -0.3 for DNA losses according
to previous experience.
Classification analysis
The support vector machine (SVM) implementation libsvm [CL01] was used
as classifier in a leave-one-out cross-validation (LOO CV) design with a grid
parameter search within the LOO CV.
Statistical and cluster analysis
Significance analysis of Microarrays (SAM) was performed on continuous and
discretised copy number ratios. The implementation of SAM for categorical
variables [Sch04] used for discretised copy number ratios differs from the
original SAM [TTC01] in the use of the Chi-squared instead of t-test sta-
tistics. Differences in the number of gains and losses between all subtypes
were evaluated using an exact Wilcoxon rank test. The distribution of geno-
mic patterns to hematogenous or lymphogenous dissemination was visualised
by hierarchical clustering (Manhattan distance, Ward linkage) including all
tumour samples.
Simulation study
A simulation study was performed to check the power of our approach given
the low number of cases. High level amplifications (log2-ratio 0.7) and low
level amplifications (log2-ratio 0.3 and 0.4) were inserted by adding 0.7, 0.3
and 0.4 at randomly chosen loci in 6 of 8 (randomly chosen) BM-positive
cases. Amplifications were simulated with a length between two and seven
genomic fragments. Missing values were not altered by the simulation. Fi-
nally, I could detect distinct high level amplifications (log2-ratio 0.7, length 4
clones) and large low level amplifications (log2-ratio 0.4, length 7 clones) with
my workflow (smoothing, classification, and statistical analysis). All analyses
were performed using the statistical language R (www.r-project.org), version
2.1.
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Results and discussion
In total, all 21 breast tumours analysed showed diverse chromosomal aber-
rations (Fig. 5.14). The mean number of DNA alterations per case was 225
with on average 102 gains and 123 losses. The most frequent DNA gains
were observed at 1q32 (in 61% of the samples), whereas the most prominent
losses were observed at 16q24 (in 35% of the samples). No statistically signifi-
cant differences in the array-CGH-patterns between patients with or without
BM or LN dissemination could be revealed. Furthermore, the classification
accuracy was always below 50%.
The assignments to the tumour class BM- were determined by an analysis
of 1 million bone marrow cells, aspirated from both sides of the upper iliac
crest. The specificity of this method is below 100 % due to the fact that single
disseminated cells are rare. That means that some patients were labeled as
BM- even if their bone marrow homed (undetected) single disseminated cells.
Our results indicate that early metastatic spread in breast cancer might not
be closely associated with a clear pattern of cytogenetic aberrations in the
primary tumour. However, to exclude an underlying genomic pattern in
relation to early metastasis the sample size of this study needs to be enlarged
and a higher array resolution could be useful. A simulation study revealed
that in this setting only distinct high level DNA gains and losses and large
single DNA losses / gains would have been found as statistically significant.
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Figure 5.14: Cluster analysis including all breast cancer samples. Each row de-
notes a case and each column a genomic fragment. A hematogenous (BM+/BM-)
or lymphogenous (LK+/LK-) dissemination pattern could not be identified. Green
represents DNA gain, red DNA loss and white balanced DNA content. Chromo-
somal aberrations were classified as DNA gain with a normalised log2 transformed
fluorescence ratio >0.3 and as loss with a ratio <-0.3. The chromosomal positions
of the genomic fragments are depicted on x axis.
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5.3 Loss of heterozygosity
5.3.1 Genomic analysis of single cytokeratin-positive
cells from bone marrow in breast cancer
Here, I describe a study published in [SMH+05]. The LOH analysis was
performed in the laboratory of Christoph Klein, University of Munich. I
contributed with a machine learning and statistical analysis.
Introduction
Recently, Christoph Klein and his co-workers found that 57% of dissemina-
ted cells isolated from the bone marrow of breast cancer patients without
clinically evident metastasis do not display chromosomal aberrations (as de-
fined by comparative genomic hybridization)[SKRD+03]. However, the mat-
ched primary tumours of the patients regularly harboured multiple chromo-
somal alterations. Thus, we reasoned that karyotypically normal cytokeratin-
positive cells in bone marrow may represent genetically very early stages of
breast cancer development — if they are indeed tumour cells.
To prove this hypothesis, we evaluated if cytokeratin-positive cells displayed
DNA damage when analysed for LOH at higher resolution using 27 micro-
satellite and two restriction fragment length polymorphism markers. We
analysed single disseminated tumour cells with normal karyotypes for chro-
mosomal aberrations, subchromosomal allelic losses and gene amplifications.
All available disseminated cells from the breast cancer patients were divided
into the following groups (M0: without clinically evident metastasis; M1:
with metastasis):
• group A: 37 cytokeratin-positive cells, M0 patients, normal CGH profile
• group B: 15 cytokeratin-positive cells, M0 patients, aberrated CGH
profile
• group C: 45 cytokeratin-positive cells, M1 patients, aberrated CGH
profile
and compared to the following control cells
• control group 1: 21 blood cells from healthy controls
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• control group 2: 52 cytokeratin-negative cells from bone-marrow of
patients with malignant epithelial cancer.
Methods
Statistical analysis
I compared the rate of LOH of all subgroups using a two-sided exact Wilcoxon
signed rank test in the software package R. To exclude a patient effect, a
simulation study by randomly choosing one cell per patient was performed.
All markers were compared using Fisher’s exact test. Noninformative cells
and homozygous losses were treated as missing values. The false discovery
rate (FDR)-controlling procedure by Benjamini and Hochberg was used to
account for multiple testing. Adjacent markers were combined in a sliding
window to enhance the reliability of the result. All measurements of three
adjacent markers were merged and compared by Fisher’s exact test.
Machine learning
The decision tree algorithm C5.0 was applied as classifier using a 10-fold
crossvalidation (CV) and a balanced design. A decision tree was used to deal
with the fact that approx. 50 % of all measurements were non-informative
and therefore missing. Imputation as a prerequisite for the use of an SVM
would have introduced a large bias. The classification accuracy was estima-
ted from 10 runs (10 × 10 CV). Noninformative markers and homozygous
losses were encoded as missing values. All calculations were performed with
the software package Clementine (http://www.spss.com/clementine/), ver-
sion 8.5. The standard errors for the accuracy values and the classification
probabilities were calculated as described by SPSS. For the control group 1,
group C and group B cells, the specificity was estimated from class assign-
ments with a classification accuracy >60%.
Results
We found that cells from control group 1 displayed significantly fewer allelic
losses than control group 2 (2.9% [95% confidence interval (CI), 0.1%–5.7%]
versus 9.8% [95% CI, 6.8%–12.8%]; p = 0.006, exact Wilcoxon rank test).
Comparing each marker separately, we found no significant differences for
any marker between control group 1 and control group 2, suggesting random
DNA loss throughout the genome.
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On average, cells from groups A, B, and C displayed 37.3% (95% CI, 32.8%-
41.8%), 48.7% (95% CI, 36.5%–60.8%) and 48.2% (95% CI, 41.7%–54.8%)
loss of informative markers, respectively. For statistical comparison of DNA
losses, we used only the control cells from the age-matched group (control
group 2). All three groups (A, B and C) showed a significantly (p < 0.001) hi-
gher percentage of LOH than control group 2 cells when evaluated by exact
Wilcoxon rank test (Fig. 5.15). Cytokeratin-positive cells that harboured
chromosomal abnormalities (groups B and C) displayed a slightly higher rate
of DNA loss than cytokeratin-positive cells with normal karyotypes (group
A). The significantly higher number of LOH in cytokeratin-positive cells wi-
thout chromosomal imbalances (group A) compared to age-matched, bone
marrow-derived cytokeratin-negative cells suggests that cytokeratin antibo-
dies identify a subpopulation within the bone marrow that displays significant
genetic instability.
We therefore attempted to define criteria by which an individual cytokeratin-
positive cell with a normal CGH profile can be identified as a tumour cell
and constructed a classifier that was trained to differentiate between group
2 control cells and group A cells. Best classification was obtained with two
markers only, D16S485 and the microsatellite marker that maps within the
beta-catenin gene. Control cells from group 2 could be separated from group
A cells with an accuracy of 74% (the 95% CI being 64%–84%; Fig. 5.16).
Generally, this classifier can be used to select breast tumour cells or control
cells on the basis of LOH markers. We tested this approach and were able
to correctly identify control cells from group 1 and tumour cells from group
B/C cells with a high specificity (88% control group 1, 90% group B/C).
In conclusion, our finding of disseminated breast cancer cells in bone marrow
that show less progressed genomic changes than preinvasive primary lesions
provides a mechanism to uncover cancer-initiating and -promoting genetic or
epigenetic alterations.
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Figure 5.15: Comparison of loss of heterozygosity of all case and control groups.
Allelic loss per cell of all tested markers evaluated for control groups 1 and 2
and cytokeratin-positive cells from groups A–C (groups A and B were from M0
stage patients, group C was from M1 stage patients, and groups B and C were
from patients with aberrant CGH profiles). Blue dots indicate heterozygous loss,
and red dots indicate homozygous deletions. Error bars represent 95% confidence
intervals.
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Figure 5.16: A classifier was trained to distinguish between control cells and
cytokeratin-positive cells without CGH aberrations. Each column denotes a geno-
mic marker and each row a cell. All markers (shown at the bottom of the figure)
are ordered according to their chromosomal location on chromosomes 3, 5, 16, and
17. Cell identifiers are given on the right side (with letter A indicating cells from
group A and letter K indicating control group 2 cells). Cells are ordered accor-
ding to their probability of being classified as cells from group A. Green colour
indicates informative markers, red indicates heterozygous loss and blue indicates
homozygous loss.
Chapter 6
General discussion and outlook
6.1 Discussion
In this thesis, I considered machine learning and its application to genomic
profiles. I studied different supervised machine learning methods and sugges-
ted a special loss function for a support vector machine and survival data.
Furthermore, I developed a workflow for machine learning of genomic profiles.
This workflow starts with preprocessing, feature selection and discretisation
of genomic profiles, includes strategies to deal with missing values and pro-
vides a multi-resolutional analysis. Then, training and analysis of a classifier
is performed.
Additionally, I propose a case-based analysis of the classification results. This
case-based analysis method can be used as an explanation scheme of a deci-
sion support system and seems to be indispensable for most clinical applica-
tions of a classification system.
My main contributions to the field of computer science apart from the work-
flow itself (chapter 4) are:
• Loss function for support vector machines and survival data
(section 2.4.3)
• Special preprocessing method for classical CGH profiles
(section 4.2.1; published in [STJE05])
• Case-based analysis of the result of classification algorithms
(section 4.4; published in [SMF+03]).
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I applied the workflow or parts of it to five different genomic data sets. The
methods used were not restricted to classification algorithms or supervised
machine learning. The toolbox of methods needed to answer the questions
raised by biologists also included unsupervised machine learning and classical
statistics.
Finally, the following questions have been analysed using these methods:
• Can sub groups of histological defined cancer types be determined?
– Principal component analysis
– Self organising maps
– Clustering
• Are genomic aberrations associated with certain clinical variables, such
as age, gender and tumour size?
– Association rules
– Classical statistics
• Are different tumour types distinguishable?
Which aberrations (signatures) distinguish one tumour type from ano-
ther?
– Decision trees
– Support vector machines
I also contributed to the field of cancer research as a co-author of publications
that revealed new knowledge about
• Early metastasis of breast cancer [HGS+08]
• Ductal and lobular breast cancer [SRS+06]
• Liposarcoma [FSW+02]
• Early breast cancer (drafted in [WSS+08])
• Loss of heterozygosity analysis of single cells [SMH+05]
Cancer can be caused by, and often correlates with, a combination of genomic
alterations. In this thesis, I contributed to the detection of new tumour
markers, namely FUS, ITGAX [SRS+06], and CCND1, MDM2, GLI, CDK4,
MYB, ESR1 and AIB1 [FSW+02].
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To summarise, this work demonstrates that machine learning methods can
improve our understanding of genomic aberrations and may help to improve
the delivery of therapies to cancer patients.
6.1.1 Customising the learning algorithm
Generally speaking, the following strategies are possible to customise the
support vector machine learning algorithm for a biological application:
1 Data preprocessing
2 Incorporation of previous knowledge as support vectors
3 Adaptation of the kernel function
4 Adaptation of the loss function
5 Domain specific interpretation of the results
Adequate data preprocessing for the domain of genomic profiles is discussed
in chapter 4. The incorporation of previous knowledge by means of artificial
support vectors was suggested by Scho¨lkopf [Sch97]. I did not use this tech-
nique because no operable previous knowledge was available in this domain.
The customisation of the kernel function (e.g. [RSS05]) should be considered
in future studies. Specifically, a customised string kernel could be used to
analyse genomic profiles with a one base pair resolution (see section 6.2.3).
So far, I have transformed the data using appropriate data preprocessing in
such a way that it could be learned by a usual kernel. A specific loss func-
tion for survival data is proposed in section 2.4.3. The interpretation of the
results of the learning algorithm is discussed in section 4.4.
6.1.2 Workflow
To the best of my knowledge, no other machine learning workflow of genomic
profiles has so far been published. Nevertheless, workflows and software
packages for analysing genomic profiles (often array CGH data) are available
(e.g. [LHN+06, WMZKM04, KNL+05]) but cover the analysis from the raw
data to the assignment of losses and gains only.
I validated the proposed workflow using different strategies. First of all, null
models (using permuted class labels) were analysed and did not reveal false
positive results (given the data sets described in chapter 5). Furthermore,
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the aberrations of a simulated data set could be detected (see section 5.2.4).
Finally, the usefulness of my approach was demonstrated by analysing geno-
mic profiles from five different biological data sets. Here, the results revealed
by machine learning were consistent with previous biological knowledge and
statistical tests (chapter 5).
The algorithm choice at each part of the workflow was directed by the litera-
ture and the biology of genomic profiles. A full search through all options at
each part of the workflow was not performed, as the search space would have
been too large (3 univariate preprocessing options × 5 multi-resolutional pre-
processing options × 5 missing value options × 2 discretisation options × 4
classification algorithms = 600 multiple tests).
Although the model selection approach depends on a distributed computing
infrastructure, it is still time consuming. Therefore, other model selection
approaches should be chosen in the future.
6.1.3 Supervised, and unsupervised machine learning
and classical statistics
Remarkably, classical statistics and supervised machine learning methods
identified similar discriminating genomic regions (e.g., Fig. 5.9). However,
both analysis methods complement each other. Classical statistics reveals
a probability that two tumour types are different whereas machine learning
provides a rule regarding the class assignment of unclassified (future) cases.
The choice of the classification algorithm seems to be not as important as long
as the features are appropriately preprocessed. However, successful classifiers
share a similar background, as this is the the case for support vector machines
and boosting. Moreover, the observed non-linearity in genomic profiles is low
due to the high dimensionality.
In addition, machine learning returns a ranked list of discriminating regions
and it is sometimes difficult to find the correct number of discriminating
regions. Even the comparison with a null model (permuted class labels)
is not always sufficient. Classical statistics seems to be the more reliable
approach here.
Association rules detect co-occurrences of events. A classic example is the
following: ”IF a customer buys nappies THEN he will also buy beer”. When
applied to genomic data sets, association rules provide thousands of rules that
have to be preselected by parsing. Moreover, association rules prefer rules
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that include frequent aberrations. Yet, frequent associations are often shared
by different tumour subtypes and therefore are not discriminative (and not
of interest).
All unsupervised machine learning methods (clustering, principal component
analysis, self-organising maps) also revealed similar results. For the liposar-
coma data set, unsupervised machine learning uncovered the correct class
separation.
A noteworthy difference between supervised and unsupervised machine lear-
ning methods is that an unsupervised method returns a hypothesis about the
structure of a data set only. Such a hypothesis has always to be proven /
retracted using classical statistics (and unseen experimental data). The co-
occurrence of cases in different subtrees of a hierarchical clustering is never
proof that these cases belong to different (cancer) subtypes. Finally, unsu-
pervised methods should be used for an exploration or visualisation of the
data set.
A second problem relates to the stability of a hypothesis uncovered by un-
supervised methods. Such a hypothesis is often very unstable and changes if
a few cases from the same population are included or excluded. Methods to
measure the stability of a cluster, after bootstrapping or adding some noise,
exist but they are not routinely used. In this thesis (section 5.1.1), I applied
a method suggested by Richard Simon [MRF+02].
6.1.4 Experimental setting and validation
So far, microarray experiments have identified thousands of candidate genes
and genomic fragments. However, the statistical validity of these candidates
remains often questionable. In addition, the overlap between candidates
of the same tumour type revealed by different research groups or different
experimental platforms is also quite low [EDZD06].
Strikingly, I often observed that classical markers (like lymph node status and
tumour size) are at least as good as markers derived from genomic and gene
expression profiles. New diagnostic markers may be successfully identified
only if the candidates are carefully chosen (according to previous knowledge)
or if the power of the underlying statistical experiment is sufficient.
The number of samples is important to draw scientific conclusions from a
machine learning model. The confidence interval of the classification accu-
racy depends on the size of the training data set. However, even in high-
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dimensional data sets large effects can be detected using a small number of
cases (this was the case for the liposarcoma-dataset) whereas small effects
require a large number of cases. Similarly, a small number of DNA probes
from different organisms is sufficient to determine differences between dif-
ferent species even though this data set is very high-dimensional (approx. 3
billion base pairs). Celera Genomics used just five individuals for revealing
the sequence of the human genome.
Subsequently, it would be desirable if more experimental biologists and phy-
sicians would consult a statistician or mathematical biologist at the design
phase of an experiment to estimate the power or minimal number of samples
to prove or falsify a hypothesis or to successfully apply a machine learning
algorithm.
Furthermore, hypotheses, which were selected by machine learning, have to
be validated using new samples. Resampling techniques like cross-validation
can never substitute an experimental validation. Finally, it remains to be
proven that a new marker outperforms current diagnostic schemes in a clinical
setting.
6.1.5 Explanation scheme
The proposed explanation scheme, including a qualitative explanation, a
competence score and a reliability score could be part of a decision support
system based on a support vector machine classifier. Fig. 6.1 visualises the
user view of such a system. The system could enable physicians to deal with
complex genomic and gene expression profiles, even if they are not experts
in molecular genetics or machine learning.
At the moment, the qualitative explanation is limited to two-class-problems,
whereas the competence and reliability estimations are able to deal with
multi-class probabilities.
As far as I am aware, another approach of a decision support system with
an explanation component based on a support vector machine has not yet
been proposed. Morik et al integrated an SVM in a decision support system
based on first-order-logic [MIB+00]. However, a case-based explanation of
the SVM classifier is not provided.
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Figure 6.1: Sketch of a user interface for a decision support system.
6.2 Future directions of research
Based on my research experience, the following directions for future research
at the intersection of computer science and biology, medicine and statistics
can be identified:
• Future research projects in bioinformatics
Future studies will be based on a larger number of cases and will the-
refore enable the detection of small genomic aberrations that correlate
and may contribute to an increased disease risk in a population. Section
6.2.2 deals with disease association studies of genomic profiles.
An important paradigm shift in biology refers to modelling rather than
a descriptive analysis. This is also the case for genomic profiles. Section
6.2.1 provides ideas for modelling genomic aberrations.
New sequencing technologies like 454 and Illumina/Solexa will enable
the sequencing of individual genomes and transcriptomes [WMW+08]
and will reveal genomic profiles at a one base pair resolution. The
challenges of analysing these data sets are discussed in section 6.2.3.
• Future research projects in computer science / statistical learning
The increasing amount of data in classification studies raises the need
142 CHAPTER 6. GENERAL DISCUSSION AND OUTLOOK
for classifiers with a low time complexity. This problem is covered in
section 6.2.4.
An unsolved problem relates to the (optimal) choice of a classification
algorithm for a given task. This issue is discussed in section 6.2.5.
• Future research projects in medical informatics
To improve cancer diagnosis and management, the knowledge gained
in cancer research has to be transferred to the point of care. A useful
tool for the deployment of this knowledge would be a decision support
system. Section 6.2.6 discusses applications of classifiers as decision
support systems in healthcare and the vision of personalised medicine.
6.2.1 Understanding cancer by modelling genomic
aberrations
Genomic and gene expression profiles improve our understanding of cancer.
However, the state-of-the-art outcome of such a study is a signature that
depicts genomic aberrations for a specific (sub) type of cancer at a specific
time point. Most of the studies reveal a descriptive view of pathological
processes only. A more comprehensive view and a mechanistic understanding
of tumorigenesis could emerge from modelling.
One example of a successfully applied model of genomic profiles is evolutio-
nary trees (e.g., [DJK+99, BRK+05, BSB+04]), revealing the order of geno-
mic aberrations. Each node of such a tree (Fig. 6.2) depicts a mutation and
each edge labels a conditional probability for this mutation. However, given
the aforementioned data sets of limited size and high dimensionality, existing
algorithms failed to discover biologically relevant knowledge.
For gene expression profiles, the modelling of transcriptional networks is an
important research topic [SFK+05]. An immense number of publications
have emerged in the field of learning signalling networks in recent years. Yet,
most of the algorithms are restricted to specific experimental designs or a
large sample number (e.g., [MBS05, Fri04, Wag01, XVDL05]). Finally, the
biological relevance of most of the existing models is limited.
The most often used graphical network models belong to the class of Bayesian
networks [BK02, Jor98]. Bayesian networks are restricted to acyclic graphs
but the biology (e.g. of intrinsic gene buffering) involves feedback loops.
Therefore, the reconstruction of cyclic graphs will be a challenge and will
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Figure 6.2: Schematic example of an oncotree. Each node depicts a mutation
and each edge labels a conditional probability for this mutation.
imply the use of Dynamic Bayesian Networks.
Another approach emerges from the field of control theory [CD02, SSS+04]
and seems to be suitable to model feedback loops. Additionally, recursive ar-
tificial neural networks could be trained with stimuli influencing cell death,
morphogenesis and differentiation. Jaeger et al. proposed in 2004 an inno-
vative method to learn such a network [JH04].
6.2.2 Large scale disease association studies
Recently, it has been found that the copy number ratios of a normal human
population are diverse [RIF+06].
The overall aim of disease association studies is to analyse copy number va-
riations in humans and their correlation to human diseases (e.g., diabetes).
Here, the challenge is to deal with the high dimensionality of the data (ap-
prox. 1 million polymorphisms). On the other hand, samples are limited
both by their availability and the cost of hybridisations.
A univariate analysis would reveal all genomic regions (given a minimal fre-
quency and length) that show a significant association with the disease. This
analysis should be corrected by using the false discovery rate.
One possible solution, to deal with the high dimensionality, would be a two-
step analysis. Step one is used to generate a hypothesis which is proven or
retracted in step two. Step one involves the study of a limited number of
144 CHAPTER 6. GENERAL DISCUSSION AND OUTLOOK
cases and all polymorphisms. A univariate analysis could then lead to a first
hypothesis. Finally, a chosen subset of hypotheses should then be analysed
in step two on new cases.
A multivariate analysis should be based on the logistic regression. However,
other methods may contribute to additional knowledge about associations.
6.2.3 Analysing genomic profiles at one base pair re-
solution
Recently, new sequencing technologies like 454 and Solexa have emerged that
reduce the costs and improve the throughput by a factor of at least one
hundred [Ben06, Car07]. I was involved in analysing and modelling of an
Eucaryotic transcriptome using such a technique [WMW+08].
The genomic profiles revealed by sequencing have a one base pair resolution
and a low-signal-to-noise ratio. In comparison, the resolution of the studies I
analysed was approx. 1000 base pairs. There is hope that future sequencing
approaches will provide an individual genomic profile (copy number variation
and structural re-arrangements) at a cost of 1000 dollars (within the next 10
years or so).
An unsolved problem is that sequence reads are small (approx. 35 base pairs)
and it is currently not possible to map all of them uniquely to a reference
genome (especially repeat regions). For the Human genome, it is estimated
that only 80% of the genome is mappable [Ben06].
From a computational point of view, sequencing produces huge amounts
of data (in the order of TBytes) and requires a massive parallel analysis
of the resulting data set. Interestingly, a genomic profile at a one-base pair
resolution could be interpreted as a string (based of the four letters A,T,G,U)
and analysed using a string kernel of a support vector machine.
6.2.4 Large scale classification problems
The time complexity of a classifier is an issue, especially for future applica-
tions like large-scale meta analyses or large-scale association studies.
Therefore I initiated, together with Stefan Hezel, a project to speed up an
SVM classifier using special hardware (FPGA, Field Programmable Gate
Arrays). In cooperation with the Department of Technical Informatics at
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the University of Mannheim, a hardware-based support of a SVM-classifier
was designed by Dirk Fuchs [Fuc05].
Another possibility is the use of classifiers with a better training time com-
plexity like Sparse Grids ([GGT01] and [GG02]) which scales linearly with
the number of samples.
To narrow down the computational complexity of the SVM learning algo-
rithm, a subset of cases in the training set could be used as base kernels
[TS01].
6.2.5 General theory of classifier choice
Currently, only ”fragments of a computational theory of learning” exist
[Mit97] and these fragments are often based on unrealistic assumptions like
noise-free training data. Examples are the statistical learning theory by Vap-
nik [Vap95] and the theory of probably approximately correct (PAC) learning
[Mit97, Hau90].
What seems to be missing is a general rule or general theory of selecting an
appropriate classification algorithm for a given classification problem. So far,
the choice of the classifier seems to be directed by personal experience and
benchmark studies using data repositories only.
However, it would be desirable to base the choice of a classifier on the struc-
ture of the decision problem and on a theory instead of a rule of thumb. So
the question emerges:
Which classifier seems to be successfully applicable considering
• the size (number of cases),
• the number of classes,
• dimensionality (number of features),
• univariate distribution (in particular discrete or continuous),
• multivariate distribution (correlation structure) and
• previous knowledge of a learning problem?
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6.2.6 Personalised medicine
Gene expression and genomic profiles can be used as diagnostic markers and
it has been shown that such profiles can outperform current diagnostic and
prognostic classification schemes. New diagnostic markers like genomic poly-
morphisms have the potential to revolutionise medical diagnostics and will fi-
nally lead to a personalised delivery of healthcare [MSMLC02]. This includes
tailoring the drug dosage and timing to individual patients, the assessment
of personal risk factors (e.g. smoking or sun) and the administration of an-
tibodies/inhibitors for proteins with an increased expression or activation.
Furthermore, kits for analysing gene expression and genomic profiles (“lab
on a chip”) or sequencing will enter the clinical practice. Yet, the integration
of gene expression and genomic profiles in the diagnostic process remains
a challenge. One possible solution is to use the knowledge generated by
bioinformatics methods in clinical decision support systems. Such systems
should enable physicians to analyse and interpret such complex profiles -
even if they are not experts in molecular genetics - as easily as analysing and
interpreting current laboratory results.
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Abbreviations
Abbreviation Description
BM Bone marrow
CGH Comparative genomic hybridisation
CI Confidence interval
CK Cytokeratin
CV Cross validation
DL Dedifferentiated liposarcoma (cancer subtype)
DNA Deoxyribonucleic acid
FDR False discovery rate
LN Lymph node
LOH Loss of heterozygosity
LOO-CV Leave-one-out cross validation
M0 Cancer patient without clinically manifest metastases
M1 Cancer patient with clinically manifest metastases
PCA Principal component analysis
PCR Polymerase chain reaction
(molecular biological technique for replicating DNA)
PL Pleiomorphic liposarcoma (cancer subtype)
R Statistical software package
RBF Radial basis function
SAM Significance analysis of microarrays
SVM Support vector machine
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Notation
Symbol Description
i, j counter
x scalar
z∗ complex conjugate of z ∈ C
x vector
xt transposed vector x
R set of real numbers
R+ set of non-negative real numbers
S training data
M = |S| number of cases
X input space
N = dim(X) dimensionality of the input space
xi input or feature vector
Y space of the target variable
yi target variable, class label of an input vector xi
K = |Y| number of classes of the target variable
F feature space
Ψ(x) mapping function from the input to the feature space
A set (list) of all feature names
f(x) decision function
F function space
ω hyperplane direction vector
ρ margin
r radius of the smallest sphere around the training data S
sign sign function
argminx f(x) argument of the minimum, returns x∗ that minimises f(x∗)
P (A) probability of an event A
p(x, y) density of a probability distribution
R(f) expected risk of a function f
Remp(f,S) empirical risk of a function f on training data S
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Symbol Description
Rreg(f,S) regularised risk of a function f on training data S
Rcross(f,S) risk of a function f on training data S
estimated by cross-validation
Rboot(f,S) empirical risk of a function f on training data S
estimated by bootstrap
L loss function
|x| absolute value of x
|S| number of elements in the set S
‖.‖2 L2 norm
‖.‖1 L1 norm
ǫ accuracy parameter
δ confidence parameter
θ Vapnik-Chervonenkis dimension (VC-dimension)
Φ regularisation operator
ξi, ξ
∗
i slack variables
si support vector
C regularisation parameter
cens censor vector, each element is 0 for a censored observation
and 1 otherwise
d degree of the polynomial kernel
γ parameter of the polynomial kernel
c parameter of the polynomial kernel
α weight vector of the decision function
and coefficients of the support vectors
b bias of the decision function
L(x) description length (in bits)
k number of partitions used in cross-validation
Li(x) Boolean expression of binary feature vectors
K(x1,x2) kernel, scalar product in feature space
T working set of a decision tree algorithm
〈.〉 scalar product in Euclidean space
〈.〉
H
scalar product in Hilbert space
x1 == x2 comparison of equality
x1 6= x2 comparison of inequality
x1 := x2 assignment, x1 becomes x2
O(.) computational complexity of an algorithm
ψu,s(x) wavelet
u translation parameter of a wavelet function
s scaling parameter of a wavelet function
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